Search Within

PROSTATE CANCER

The Role of Insulin-Like Growth Factor I Components in the Regulation of Vitamin D

Journal: Current Pharmaceutical Biotechnology
Volume: 7,Issue: 2
Page: 125-132
Authors: Jose Manuel Gomez

Antagonists of Growth Hormone-Releasing Hormone in Oncology

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 9,Issue: 3
Page: 163-170
Authors: Andrew V. Schally and Jozsef L. Varga


Treatment of PSA only Recurrence of Prostate Cancer After Prior Local Therapy

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 7
Page: 785-798
Authors: Judd W. Moul

Controversies of Androgen Ablation Therapy for Metastatic Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 7
Page: 799-805
Authors: Shandra S. Wilson and E. D. C.

Immunotherapy for Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 7
Page: 807-817
Authors: R. J. K., Christopher M. Whelan and Eugene D. Kwon

Chemotherapy for Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 7
Page: 819-837
Authors: Sara W. Dyrstad, Prabodh Shah and K. Rao

Natural and Synthetic Retinoids in Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 15
Page: 1923-1929
Authors: D. Pasquali, V. Rossi, G. Bellastella, A. Bellastella and A. A. Sinisi

Matrix Metalloproteinases in Cancer Metastasis: Molecular Targets for Prostate Cancer Prevention by Green Tea Polyphenols and Grape Seed Proanthocyanidins

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6,Issue: 1
Page: 17-24
Authors: Santosh K. Katiyar

Roles of Type 10 17beta-Hydroxysteroid Dehydrogenase in Intracrinology and Metabolism of Isoleucine and Fatty Acids

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6,Issue: 1
Page: 95-102
Authors: X.- Y. He and S.- Y. Yang

The Role of Genistein and Synthetic Derivatives of Isoflavone in Cancer Prevention and Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 6,Issue: 4
Page: 401-407
Authors: Fazlul H. Sarkar, Shreelekha Adsule, Subhash Padhye, Sudhir Kulkarni and Yiwei Li

Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 5
Page: 405-421
Authors: Stephen V. Frye

Antisense Oligodeoxynucleotide Therapy for Prostate Cancer Targeting Antiapoptotic Genes Involved in the Mechanism Mediating Progression to Androgen Independence

Journal: Current Signal Transduction Therapy
Volume: 1,Issue: 2
Page: 219-226
Authors: Hideaki Miyake, Isao Hara, Masato Fujisawa and Martin E. Gleave

Angiotensin II Receptor Blocker: Possibility of Antitumor Agent for Prostate Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 6,Issue: 7
Page: 835-844
Authors: Hiroji Uemura, Hitoshi Ishiguro and Yoshinobu Kubota

Knowledge of Epigenetic Influence for Prostate Cancer Therapy

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 6
Page: 533-551
Authors: Masatoshi Watanabe, Akimitsu Takagi, Takeshi Matsuzaki, Daisuke Kami, Minoru Toyota, Yoshifumi Hirokawa and Taizo Shiraishi

Phosphodiesterase 5 Inhibitors - Drug Design and Differentiation Based on Selectivity, Pharmacokinetic and Efficacy Profiles

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 27
Page: 3459-3465
Authors: Claudiu T. Supuran, Antonio Mastrolorenzo, Giuseppe Barbaro and Andrea Scozzafava

Adrenomedullin: A Tumor Progression Factor via Angiogenic Control

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 7
Page: 635-643
Authors: Misa Nakamura, Bo Han, Osamu Nunobiki and Kennichi Kakudo

Benign Prostatic Hyperplasia and Clinical Prostate Cancer - Two New Components of the Metabolic Syndrome

Journal: Current Hypertension Reviews
Volume: 2,Issue: 4
Page: 301-309
Authors: Hammarsten Jan

Retinoblastoma Regulatory Pathway in Lung Cancer

Journal: Current Molecular Medicine
Volume: 6,Issue: 7
Page: 783-793
Authors: Kathryn A. Wikenheiser-Brokamp

Modulation of the Cell Cycle and Induction of Apoptosis in Human Cancer Cells by Synthetic Bile Acids

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 8
Page: 681-689
Authors: Nam Deuk Kim, Eunok Im, Young Hyun Yoo and Yung Hyun Choi

The Multifaceted Roles of Osteopontin in Cell Signaling, Tumor Progression and Angiogenesis

Journal: Current Molecular Medicine
Volume: 6,Issue: 8
Page: 819-830
Authors: Goutam Chakraborty, Shalini Jain, Reeti Behera, Mansoor Ahmed, Priyanka Sharma, Vinit Kumar and Gopal C. Kundu

Sensor/Effector Drug Design with Potential Relevance to Cancer

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 34
Page: 4479-4499
Authors: Fiona H. Fry and Claus Jacob

Role of Endogenous Androgen Against Insulin Resistance and Athero-sclerosis in Men with Type 2 Diabetes

Journal: Current Diabetes Reviews
Volume: 3,Issue: 1
Page: 25-31
Authors: Michiaki Fukui, Yoshihiro Kitagawa, Hiroyuki Ose, Goji Hasegawa, Toshikazu Yoshikawa and Naoto Nakamura

Molecular and Genetic Profiling of Prostate Cancer: Implications for Future Therapy

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 1
Page: 25-36
Authors: Gregory Saia, Min Zhang, Vincent Depalo, Tim Lautenschlager and Arnab Chakravarti

Diagnostic Methods in the Detection of Prostate Cancer: Prospective Observational Study

Journal: Current Medical Imaging Reviews
Volume: 3,Issue: 1
Page: 27-35
Authors: Juan-Bosco Lopez-Saez, Milagros Otero, Margarita Dominguez Villar, Antonio Lorenzo Penuelas, Pedro Rodriguez Navarro, Pedro Gallurt Moreira and sAvelino Senra-Varela

Mechanisms of T Cell Tolerance and Suppression in Cancer Mediated by Tumor-Associated Antigens and Hormones

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 1
Page: 3-14
Authors: Adam J. Adler

The IGF Axis in Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 7
Page: 719-727
Authors: S. Monti, L. Proietti-Pannunzi, A. Sciarra, F. Lolli, P. Falasca, M. Poggi, F. S. Celi and V. Toscano

MUC1 is a Promising Therapeutic Target for Prostate Cancer Therapy

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 3
Page: 259-271
Authors: Y. Li and P. J. Cozzi

Transcription Factors: Molecular Targets for Prostate Cancer Intervention by Phytochemicals

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 4
Page: 355-367
Authors: Manjinder Kaur and Rajesh Agarwal

The Wnt/Beta-Catenin Pathway in Wilms Tumors and Prostate Cancers

Journal: Current Molecular Medicine
Volume: 7,Issue: 5
Page: 479-489
Authors: Benjamin Tycko, Chi-Ming Li and Ralph Buttyan

The Role of Stress Proteins in Prostate Cancer

Journal: Current Genomics
Volume: 8,Issue: 4
Page: 252-261
Authors: Alan So, Boris Hadaschik, Richard Sowery and Martin Gleave

Cross-Talk Between the Androgen Receptor and the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 6
Page: 591-604
Authors: Yu Wang, Jeffrey I. Kreisberg and Paramita M. Ghosh

Anti-Angiogenesis and RGD-Containing Snake Venom Disintegrins

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 28
Page: 2860-2871
Authors: Stephen Swenson, Swapnika Ramu and Francis S. Markland

Src Family Nonreceptor Tyrosine Kinases as Molecular Targets for Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 7,Issue: 6
Page: 651-659
Authors: Faye M. Johnson and Gary E. Gallick

Purinergic (P2) Receptor Control of Lower Genitourinary Tract Function and New Avenues for Drug Action: An Overview

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 31
Page: 3236-3244
Authors: Serap Gur, Philip J. Kadowitz and Wayne J.G. Hellstrom

Novel Biological Agents for the Treatment of Hormone-Refractory Prostate Cancer (HRPC)

Journal: Current Medicinal Chemistry
Volume: 12,Issue: 3
Page: 277-296
Authors: A. G. Papatsoris, M. V. Karamouzis and A. G. Papavassiliou

Gene Therapy Strategies in Prostate Cancer

Journal: Current Gene Therapy
Volume: 5,Issue: 1
Page: 1-10
Authors: Iris E. Eder, Petra Haag, Georg Bartsch and Helmut Klocker

In Situ Gene Therapy for Prostate Cancer

Journal: Current Gene Therapy
Volume: 5,Issue: 1
Page: 111-119
Authors: Takefumi Satoh, Akira Irie, Shin Egawa and Shiro Baba

Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors

Journal: Current Medicinal Chemistry
Volume: 12,Issue: 8
Page: 927-943
Authors: Eugene Bratoeff, Marisa Cabeza, Elena Ramirez, Yvonne Heuze and Eugenio Flores

The Antagonists of Endothelin Receptors: Results and Perspectives

Journal: Current Pharmaceutical Analysis
Volume: 1,Issue: 1
Page: 93-108
Authors: Alessandro Cosenzi

Stromal Derived Growth Factor-1alpha as a Beacon for Stem Cell Homing in Development and Injury

Journal: Current Neurovascular Research
Volume: 2,Issue: 4
Page: 319-329
Authors: C. M. Claps, K. E. Corcoran, K. J. Cho and P. Rameshwar

A Short Review of Analytical Methods for the Determination of Estramustine Phosphate and its Metabolites in Biological Samples

Journal: Current Pharmaceutical Analysis
Volume: 1,Issue: 2
Page: 195-201
Authors: Massimo Breda and Christopher A. James

METCAM/MUC18 Expression and Cancer Metastasis

Journal: Current Genomics
Volume: 6,Issue: 5
Page: 333-349
Authors: G- J. Wu

RUNX3 and Retinoic Acid Receptor β DNA Methylation as Novel Targets for Gastric Cancer Therapy

Journal: Current Cancer Therapy Reviews
Volume: 1,Issue: 2
Page: 139-144
Authors: Eiichi Tahara and Reuben Lotan

Androgen Receptor Coregulatory Proteins as Potential Therapeutic Targets in the Treatment of Prostate Cancer

Journal: Current Cancer Therapy Reviews
Volume: 1,Issue: 2
Page: 175-186
Authors: Hannelore V. Heemers and Donald J. Tindall

Inhibition of P450 17 as a New Strategy for the Treatment of Prostate Cancer

Journal: Current Medicinal Chemistry
Volume: 12,Issue: 14
Page: 1623-1629
Authors: F. Leroux

Novel Antisense Anti-MDM2 Mixed-Backbone Oligonucleotides: Proof of Principle, In Vitro and In Vivo Activities, and Mechanisms

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 1
Page: 43-49
Authors: Ruiwen Zhang, Hui Wang and Sudhir Agrawal

Chemosensitization by Antisense Oligonucleotides Targeting MDM2

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 1
Page: 51-56
Authors: Roberto Bianco, Fortunato Ciardiello and Giampaolo Tortora

Cytostatic Effect of the Nucleoside Analogue 2-Chloroadenosine on Human Prostate Cancer Cell Line

Journal: Current Pharmaceutical Analysis
Volume: 1,Issue: 3
Page: 265-272
Authors: Ilaria Bellezza, Massimiliano Agostini, Lavinia Liguori and Alba Minelli

Folate-Linked Lipid-Based Nanoparticle for Targeted Gene Delivery

Journal: Current Drug Delivery
Volume: 2,Issue: 3
Page: 243-252
Authors: Yoshiyuki Hattori and Yoshie Maitani

Antiproliferative Efficacy of Angiotensin II Receptor Blockers in Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 5
Page: 307-323
Authors: Hiroji Uemura, Noboru Nakaigawa, Hitoshi Ishiguro and Yoshinobu Kubota

Hypomethylation of Urokinase (uPA) Promoter in Breast and Prostate Cancer: Prognostic and Therapeutic Implications

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 7
Page: 471-488
Authors: Pouya Pakneshan, Moshe Szyf and Shafaat A. Rabbani

The Effects of Dietary Factors on the Androgen Receptor and Related Cellular Factors in Prostate Cancer

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 7
Page: 909-923
Authors: Charles Y.F. Young, Aminah Jatoi, John F. Ward and Michael L. Blute

Antiandrogens in Prostate Cancer Endocrine Therapy

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 5
Page: 455-461
Authors: Z. Culig, G. Bartsch and A. Bartsch

Cytochrome P450 Gene Polymorphism and Cancer

Journal: Current Drug Metabolism
Volume: 5,Issue: 3
Page: 211-224
Authors: Jose A.G. Agundez

Protein Kinase C and Prostate Carcinogenesis: Targeting the Cell Cycle and Apoptotic Mechanisms

Journal: Current Drug Targets
Volume: 5,Issue: 5
Page: 431-443
Authors: M. Veronica Gavrielides, Anita F. Frijhoff, Claudio J. Conti and Marcelo G. Kazanietz

New Features in the Treatment of Androgen-Independent Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 5
Page: 513-522
Authors: Jean Closset, Hayet Ammar, Viet-Ha Nguyen, Anne Cornet and Eric Reiter

Molecular Therapy Intervention Prospects in Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 5
Page: 523-530
Authors: Yashraj D. Rege and Vivek M. Rangnekar

Targeting Gene Therapy for Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 5
Page: 531-555
Authors: N. J. Maitland, L. J. Stanbridge and V. Dussupt

Genetic Abnormalities in Prostate Cancer

Journal: Current Genomics
Volume: 5,Issue: 1
Page: 67-83
Authors: Sanjeev Shukla, Gregory T. MacLennan, Susan R. Marengo, Allen D. Seftel, Martin I. Resnick and Sanjay Gupta

Novel Insights and Therapeutical Applications in the Field of Inhibitors of COX-2

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 24
Page: 3147-3161
Authors: W. Kiefer and G. Dannhardt

Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 6
Page: 471-482
Authors: E. Papadimitriou, A. Polykratis, M. Hatziapostolou, A. Parthymou, C. Polytarchou and C. Mikelis

Prostate Cancer Prevention by Silibinin

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 1
Page: 1-11
Authors: Rana P. Singh and Rajesh Agarwal

Apoptosis is a Critical Cellular Event in Cancer Chemoprevention and Chemotherapy by Selenium Compounds

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 1
Page: 13-28
Authors: R. Sinha and K. El-Bayoumy

Novel Targeting of Apoptosis Pathways for Prostate Cancer Therapy

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 1
Page: 85-95
Authors: Jason B. Garrison and Natasha Kyprianou

Integrin αvβ3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis

Journal: Current Drug Targets
Volume: 4,Issue: 2
Page: 123-131
Authors: C. Chandra Kumar

Inhibitors of 17β-Hydroxysteroid Dehydrogenases

Journal: Current Medicinal Chemistry
Volume: 10,Issue: 6
Page: 453-477
Authors: Donald Poirier

Cancer Chemoprevention Drug Targets

Journal: Current Drug Targets
Volume: 4,Issue: 1
Page: 45-54
Authors: K. Krishnan, S. Campbell, F. Abdel-Rahman, S. Whaley and W. L. Stone

Tumor Cell Hypoxia and the Hypoxia-Response Signaling System as a Target for Prostate Cancer Therapy

Journal: Current Drug Targets
Volume: 4,Issue: 3
Page: 191-196
Authors: Aristotelis G. Anastasiadis, Debra L. Bemis, Brian C. Stisser, Laurent Salomon, Mohamed A. Ghafar and Ralph Buttyan

TGF-ß / Smad Signaling in Prostate Cancer

Journal: Current Drug Targets
Volume: 4,Issue: 3
Page: 197-207
Authors: Diana Bello-DeOcampo and Donald J. Tindall

Antisense Targets to Enhance Hormone and Cytotoxic Therapies in Advanced Prostate Cancer

Journal: Current Drug Targets
Volume: 4,Issue: 3
Page: 209-221
Authors: Martin Gleave, Colleen Nelson and Kim Chi

Par-4 for Molecular Therapy of Prostate Cancer

Journal: Current Drug Targets
Volume: 4,Issue: 3
Page: 223-230
Authors: James Butler and Vivek M. Rangnekar

Phytoestrogens and Prostate Cancer

Journal: Current Drug Targets
Volume: 4,Issue: 3
Page: 231-241
Authors: Colm Morrissey and R. William G. Watson

Therapeutic Targets for Metastatic Prostate Cancer

Journal: Current Drug Targets
Volume: 4,Issue: 3
Page: 251-261
Authors: Terry L. Timme, Takefumi Satoh, Salahaldin A. Tahir, Hongyu Wang, Bin S. The, E. Brian Butler, Brian J. Miles, Robert J. Amato, Dov Kadmon and Timothy C. Thompson

Mouse Strains for Prostate Tumorigenesis Based on Genes Altered in Human Prostate Cancer

Journal: Current Drug Targets
Volume: 4,Issue: 3
Page: 263-279
Authors: W. C. Powell, R. D. Cardiff, M. B. Cohen, G. J. Miller and P. Roy-Burman

Drug-Targeting Strategies for Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 6
Page: 455-466
Authors: Gil Ast

Neuropeptides as Autocrine Growth Factors in Cancer Cells

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 6
Page: 495-509
Authors: Terry W. Moody, Daniel Chan, Jan Fahrenkrug and Robert T. Jensen

Role of Maspin in Tumor Metastasis and Angiogenesis

Journal: Current Molecular Medicine
Volume: 3,Issue: 7
Page: 653-658
Authors: Jeremy S. Schaefer and Ming Zhang

Integrated, Molecular Engineering Approaches to Develop Prostate Cancer Gene Therapy

Journal: Current Gene Therapy
Volume: 3,Issue: 5
Page: 452-467
Authors: Lily Wu and Makoto Sato

Bradykinin Antagonists as Anti-Cancer Agents

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 25
Page: 2036-2042
Authors: J. M. Stewart

Akt in Prostate Cancer: Possible Role in Androgen-Independence

Journal: Current Drug Metabolism
Volume: 4,Issue: 6
Page: 487-496
Authors: Paramita M. Ghosh, Shazli Malik, Roble Bedolla and Jeffrey I. Kreisberg

The Clinical Applications of Heat Shock Protein Inhibitors in Cancer - Present and Future

Journal: Current Cancer Drug Targets
Volume: 3,Issue: 5
Page: 385-390
Authors: Udai Banerji, Ian Judson and Paul Workman

Role of Oxidative Stress Response Elements and Antioxidants in Prostate Cancer Pathobiology and Chemoprevention -- A Mechanistic Approach

Journal: Current Medicinal Chemistry
Volume: 10,Issue: 24
Page: 2679-2692
Authors: Suresh C. Sikka

Growth Factors, Cytokines and Dendritic Cell Development

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 5
Page: 405-418
Authors: S. Vuckovic, G. J. Clark and D. N.J. Hart

A Transporter Gene (Sodium Iodide Symporter) for Dual Purposes in Gene Therapy: Imaging and Therapy

Journal: Current Gene Therapy
Volume: 2,Issue: 4
Page: 393-402
Authors: Je-Yoel Cho

CMT-3, a Non-antimicrobial Tetracycline (TC), Inhibits MT1-MMP Activity: Relevance to Cancer

Journal: Current Medicinal Chemistry
Volume: 8,Issue: 3
Page: 257-260
Authors: M. H. Lee, M. L. Golub, J. Cao, O. Teronen, M. Laitinen, T. Salo, S. Zucker and T. Sorsa

Cytotoxic Activity and Inhibition of Tumor Cell Invasion by Derivatives of a Chemically Modified Tetracycline CMT-3 (COL-3)

Journal: Current Medicinal Chemistry
Volume: 8,Issue: 3
Page: 271-279
Authors: Bal L. Lokeshwar, Eva Escatel and Baoqian Zhu

Viral Based Gene Therapy for Prostate Cancer

Journal: Current Gene Therapy
Volume: 1,Issue: 2
Page: 183-200
Authors: Yi Lu

Nuclear Targeting and Retention of Anthracycline Antitumor Drugs in Sensitive and Resistant Tumor Cells

Journal: Current Medicinal Chemistry
Volume: 8,Issue: 1
Page: 15-29
Authors: Dylan J. Taatjes and Tad H. Koch

D-RNAi (Messenger RNA-antisense DNA Interference) as a Novel Defense System Against Cancer and Viral Infections.

Journal: Current Cancer Drug Targets
Volume: 1,Issue: 3
Page: 241-247
Authors: Shi-Lung Lin and Shao-Yao Ying

The Use of Fas Ligand, TRAIL and Bax in Gene Therapy of Prostate Cancer

Journal: Current Gene Therapy
Volume: 1,Issue: 1
Page: 123-136
Authors: J. S. Norris, M. L. Hyer, C. Voelkel-Johnson, S. L. Lowe, S. Rubinchik and J-Y. Dong

The Pathogenesis of Lung Cancer and Chromosome 11

Journal: Current Genomics
Volume: 1,Issue: 3
Page: 281-288
Authors: Diana M. Pitterle, Young-Chul Kim, Youjia Cao, Ashish Gautam, Baohui Zhao, Amy Beck and Gerold Bepler

Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships

Journal: Current Medicinal Chemistry
Volume: 7,Issue: 2
Page: 211-247
Authors: Shankar M. Singh, Sylvain Gauthier and Fernand Labrie

Recent Approaches in Chemoprevention of Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 7
Page: 681-688
Authors: Charles Y.F. Young

Radiosensitization of Prostate Cancer by Soy Isoflavones

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 8
Page: 759-765
Authors: Julian J. Raffoul, Fazlul H. Sarkar and Gilda G. Hillman

Natural and Synthetic Agents Targeting Inflammation and Angiogenesis for Chemoprevention of Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 2
Page: 146-155
Authors: Spiridione Garbisa, Elena M.V. Araldi, Isabella Dell'Aica, Ilaria Sogno, Girieca Lorusso and Adriana Albini

CYP17 Inhibitors for Prostate Cancer Treatment – An Update

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 9
Page: 868-899
Authors: V. M. Moreira, J. A.R. Salvador, T. S. Vasaitis and V. C.O. Njar

Circulating Levels of VCAM and MMP-2 May Help Identify Patients with More Aggressive Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 3
Page: 199-206
Authors: Concetta De Cicco, Laura Ravasi, Laura Zorzino, Maria Teresa Sandri, Edoardo Botteri, Fabrizio Verweij, Donatella Granchi, Ottavio de Cobelli and Giovanni Paganelli

Overview of Prostate Biomarkers as Potential Targets for Immunotherapy

Journal: Current Cancer Therapy Reviews
Volume: 4,Issue: 2
Page: 86-95
Authors: Amanda K. Miles, Alistair Roger, Richard Parkinson, Robert C. Rees and Stephanie E.B. McArdle

Wnt Signaling and Prostate Cancer

Journal: Current Drug Targets
Volume: 9,Issue: 7
Page: 271-580
Authors: Daniel R. Robinson, Cassandra R. Zylstra and Bart O. Williams

Polymorphisms of Human N-Acetyltransferases and Cancer Risk

Journal: Current Drug Metabolism
Volume: 9,Issue: 6
Page: 520-531
Authors: Jose A.G Agundez

Prostatic Tumor Stroma: A Key Player in Cancer Progression

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 6
Page: 490-497
Authors: R. A. Taylor and G. P. Risbridger

Recent Developments of Steroid Sulfatase Inhibitors as Anti-Cancer Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8,Issue: 7
Page: 732-738
Authors: Paul A. Foster, Michael J. Reed and Atul Purohit

2-Chloroadenosine and Human Prostate Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8,Issue: 7
Page: 783-789
Authors: I. Bellezza, A. Tucci and A. Minelli

Cell-Specific Induction of Apoptosis by Rationally Designed Bivalent Aptamer-siRNA Transcripts Silencing Eukaryotic Elongation Factor 2

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 7
Page: 554-565
Authors: Ulrich Wullner, Inga Neef, Andreas Eller, Michael Kleines, Mehmet Kemal Tur and Stefan Barth

Notch Signaling: A Potential Therapeutic Target in Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 7
Page: 566-580
Authors: M. A. Villaronga, C. L. Bevan and B. Belandia

In vivo Cancer Imaging with Semiconductor Quantum Dots

Journal: Current Pharmaceutical Analysis
Volume: 4,Issue: 4
Page: 197-205
Authors: Giulia Bertolini, Laura Paleari, Alessia Catassi, Luca Roz, Alfredo Cesario, Gabriella Sozzi and Patrizia Russo

PET Imaging of Steroid Receptor Expression in Breast and Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 28
Page: 3020-3032
Authors: G. A.P. Hospers, F. A. Helmond, E. G.E. de Vries, R. A. Dierckx and E. F.J. de Vries

Nuclear Imaging of Prostate Cancer with Gastrin-Releasing-Peptide- Receptor Targeted Radiopharmaceuticals

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 28
Page: 3033-3047
Authors: H. J.K. Ananias, I. J. de Jong, R. A. Dierckx, C. van de Wiele, W. Helfrich and P. H. Elsinga

Overview of Tumor-Associated Antigens (TAAs) as Potential Therapeutic Targets for Prostate Cancer Therapy

Journal: Current Cancer Therapy Reviews
Volume: 4,Issue: 4
Page: 271-284
Authors: Paul J. Cozzi, John Kearsley and Yong Li

Protective Effect of NSAIDs on Cancer and Influence of COX-2 C G Genotype

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 8
Page: 753-764
Authors: C. Siemes, L. E. Visser, J. W.W. Coebergh, A. Hofman, A. G. Uitterlinden and B.H. Ch. Stricker

Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen

Journal: Current Drug Targets
Volume: 10,Issue: 2
Page: 118-125
Authors: U. Elsasser-Beile, P. Buhler and P. Wolf

The Estrogenic Burden on Vascular Risk in Male-to-Female Transsexuals

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 34
Page: 3815-3822
Authors: Eirini Lioudaki, Emmanuel S. Ganotakis, Dimitri P. Mikhailidis and Devaki R. Nair

A Trojan Horse in Drug Development: Targeting of Thapsigargins Towards Prostate Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 3
Page: 276-294
Authors: S. Brogger Christensen, Dorthe Mondrup Skytte, Samuel R. Denmeade, Craig Dionne, Jesper Vuust Moller, Poul Nissen and John T. Isaacs

Role of the Akt Pathway in Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 2
Page: 163-175
Authors: Paul L. de Souza, Pamela J. Russell and John Kearsley

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 2
Page: 237-249
Authors: Todd M. Morgan, Theodore D. Koreckij and Eva Corey

The Role of Androgen Receptor Mutations in Prostate Cancer Progression

Journal: Current Genomics
Volume: 10,Issue: 1
Page: 18-25
Authors: G. N. Brooke and C. L. Bevan

A Fresh Prospect of Extracellular Matrix Hydrolytic Enzymes and Their Substrates

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 12
Page: 1295-1308
Authors: M. D. Roycik, X. Fang and Q.-X. Sang

Synergetic Bitherapy in Mice with Xenografts of Human Prostate Cancer Using a Methional Mimic (METLICO) and an Aldehyde Dehydrogenase 3 Inhibitor (MATE): Systemic Intraperitoneal (IP) and Targeted Intra-Tumoral (IT) Administration

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 10
Page: 1184-1191
Authors: E. Hiltbrand, G. Fournet, J-P. Giliberto, M-J. Paret, J. Chantepie, D. Morel, J. Gore, U. Reichert, H. Mehier, M-E. Rochedix and G. Quash

The Role of the Calcium-Sensing Receptor in Bone Biology and Pathophysiology

Journal: Current Pharmaceutical Biotechnology
Volume: 10,Issue: 3
Page: 289-301
Authors: T. A. Theman and M. T. Collins

CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 3
Page: 287-306
Authors: J.L. Hao, P.J. Cozzi, A. Khatri, C.A. Power and Y. Li

Persistent P21Cip1 Induction Mediates G1 Cell Cycle Arrest by Methylseleninic Acid in DU145 Prostate Cancer Cells

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 3
Page: 307-318
Authors: Z. Wang, H.-J. Lee, Y. Chai, H. Hu, L. Wang, Y. Zhang, C. Jiang and J. Lu

17α-Hydroxylase/17,20-Lyase (P450 ) Inhibitors in the Treatment of Prostate Cancer: A Review

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 6
Page: 613-626
Authors: Caroline P. Owen

Advances in Development of Inhibitors of 17β-Hydroxysteroid Dehydrogenases

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 6
Page: 642-660
Authors: Donald Poirier

Fibroblast Growth Factors in Development and Cancer: Insights from the Mammary and Prostate Glands

Journal: Current Drug Targets
Volume: 10,Issue: 7
Page: 632-644
Authors: Kathryn L. Schwertfeger

Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 8
Page: 904-912
Authors: Q. Shi, C. C.-Y. Shih and K. H. Lee

Prophylaxis of Erectile Function After Radical Prostatectomy with Phosphodiesterase Type 5 Inhibitors

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 30
Page: 3496-3501
Authors: F. Deho, A. Gallina, A. Salonia, A. Briganti, N. Suardi, G. Zanni, G. Guazzoni, P. Rigatti and F. Montorsi

Editorial [Hot topic: Prostate Cancer Therapy (Guest Editors: N. Sharifi and J.B. Aragon-Ching)]

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 1039-1039
Authors: N. Sharifi and J. B. Aragon-Ching

Cytotoxic Compounds in the Treatment of Castration-Resistant Prostate Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 1040-1045
Authors: Patrick Lee and Jeanny B. Aragon-Ching

Hormonal Therapy for Prostate Cancer: Toward Further Unraveling of Androgen Receptor Function

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 1046-1051
Authors: Nima Sharifi

Current Perspectives in Prostate Cancer Vaccines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 1052-1057
Authors: Philip M. Arlen and James L. Gulley

Current Status of Thalidomide and CC-5013 in the Treatment of Metastatic Prostate Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 1058-1069
Authors: Tristan M. Sissung, Silja Thordardottir, Erin R. Gardner and William D. Figg

Angiogenesis Inhibition in the Treatment of Prostate Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 1070-1078
Authors: Ravi A. Madan and William L. Dahut

Agents Targeting Prostate Cancer Bone Metastasis

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 1079-1088
Authors: Khalid S. Mohammad, Pierrick G. Fournier, Theresa A. Guise and John M. Chirgwin

Kinase Inhibitors in Prostate Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 1089-1104
Authors: Suwicha Limvorasak and Edwin M. Posadas

Targeting Prostate Cancer Stem Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 1105-1113
Authors: Francesco Crea, Lesley A. Mathews, William L. Farrar and Elaine M. Hurt

Anti-Tumour Effects of Bisphosphonates - What have we Learned from In Vivo Models?

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 7
Page: 807-823
Authors: H. K. Brown and I. Holen

HIF-1α and Calcium Signaling as Targets for Treatment of Prostate Cancer by Cardiac Glycosides

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 7
Page: 881-887
Authors: J. Lin, S. Denmeade and M. A. Carducci

Meet the Guest Editor

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 12,Issue: 10
Page: 1017-1017
Authors: Alan C. Rigby

Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 4
Page: 411-420
Authors: David Hirst and Tracy Robson

A Pilot Study on Prostate Cancer Risk and Pro-Inflammatory Genotypes: Pathophysiology and Therapeutic Implications

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 6
Page: 718-724
Authors: C. R. Balistreri, C. Caruso, G. Carruba, V. Miceli, I. Campisi, F. Listi, D. Lio, G. Colonna-Romano and G. Candore

Peptide Antagonist of the Androgen Receptor

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 9
Page: 1106-1113
Authors: Wenqing Gao

Antisense Treatment in Human Prostate Cancer and Melanoma

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 6
Page: 555-565
Authors: C. Di Cresce and J. Koropatnick

Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 11
Page: 1272-1283
Authors: C.H. Buckle, H.L. Neville-Webbe, P.I. Croucher and M.A. Lawson

The CXCR4/SDF-1 Chemokine Axis: A Potential Therapeutic Target for Bone Metastases?

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 11
Page: 1284-1290
Authors: A.C. Hirbe, E.A. Morgan and K.N. Weilbaecher

Bone Morphogenetic Proteins and its Receptors; Therapeutic Targets in Cancer Progression and Bone Metastasis?

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 11
Page: 1291-1300
Authors: Jeroen T. Buijs, Maj Petersen, Geertje van der Horst and Gabri van der Pluijm

TGF-β Pathway as a Therapeutic Target in Bone Metastases

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 11
Page: 1301-1312
Authors: Patricia Juarez and Theresa A. Guise

Interferon Therapy for Malignant Solid Tumors

Journal: Current Drug Therapy
Volume: 5,Issue: 2
Page: 132-138
Authors: Katherine E. Warren and Howard A. Young

Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family Proteins

Journal: Current Drug Targets
Volume: 11,Issue: 6
Page: 699-707
Authors: David Karnak and Liang Xu

Targeting Apoptosis Pathway with Natural Terpenoids: Implications for Treatment of Breast and Prostate Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 6
Page: 733-744
Authors: Huanjie Yang and Q. Ping Dou

Targeting CREB for Cancer Therapy: Friend or Foe

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 4
Page: 384-391
Authors: X. Xiao, B.X. Li, B. Mitton, A. Ikeda and K.M. Sakamoto

Molecular Pathways in the Progression of Hormone-Independent and Metastatic Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 4
Page: 392-401
Authors: B. Wegiel, S. Evans, R. Hellsten, L.E. Otterbein, A. Bjartell and J.L. Persson

Recent Advances in Understanding Hormonal Therapy Resistant Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 4
Page: 402-410
Authors: K.V. Donkena, H. Yuan and C.Y. Young

Positron Emission Tomography and Computer Tomography (PET/CT) in Prostate, Bladder, and Testicular Cancers

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 23
Page: 2492-2502
Authors: A. Zouhair, M. Ozsahin, M. Schaffer, S. Albrecht, F. Camus, P. Jichlinski, R.-O. Mirimanoff, A. Bischof Delaloye, J.-Y. Meuwly and J.O. Prior

New Therapies for Prostate Cancer Based on the Biology of Androgen Receptor Coregulators

Journal: Current Cancer Therapy Reviews
Volume: 6,Issue: 3
Page: 185-198
Authors: Yuexing Zhang and Anne W. Hamburger

Chemoprevention of Lung Pathologies by Dietary n-3 Polyunsaturated Fatty Acids

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 29
Page: 3358-3376
Authors: E. Fasano, S. Serini, E. Piccioni and G. Calviello

Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 7
Page: 695-704
Authors: C. Falciani, B. Lelli, J. Brunetti, S. Pileri, A. Cappelli, A. Pini, C. Pagliuca, N. Ravenni, L. Bencini, S. Menichetti, R. Moretti, M. De Prizio, M. Scatizzi and L. Bracci

Use of Transgenic Mice as Models for Prostate Cancer Chemoprevention

Journal: Current Molecular Medicine
Volume: 10,Issue: 8
Page: 705-718
Authors: P. A. Nguewa and A. Calvo

Prevention and Treatment of Bone Metastases

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 27
Page: 2998-3006
Authors: E. J. Woodward and R. E. Coleman

Dietary Agents for Prostate Cancer Chemoprevention: An Overview

Journal: Current Cancer Therapy Reviews
Volume: 6,Issue: 4
Page: 308-316
Authors: Natalie A. Venier, Laurence H. Klotz, Neil E. Fleshner and Vasundara Venkateswaran

Fighting Tumor Cell Survival: Advances in the Design and Evaluation of Pim Inhibitors

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 34
Page: 4114-4133
Authors: F. Anizon, A. A. Shtil, V. N. Danilenko and P. Moreau

RAS Pathways in Prostate Cancer - Mediators of Hormone Resistance?

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 8
Page: 834-839
Authors: H. C. Whitaker and D. E. Neal

Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors

Journal: Current Drug Delivery
Volume: 8,Issue: 1
Page: 11-25
Authors: Andrew V. Schally, Jorg B. Engel, Gunter Emons, Norman L. Block and Jacek Pinski

The Emerging Pharmacology of TRPM8 Channels: Hidden Therapeutic Potential Underneath a Cold Surface

Journal: Current Pharmaceutical Biotechnology
Volume: 12,Issue: 1
Page: 54-67
Authors: Annika Malkia, Cruz Morenilla-Palao and Felix Viana

FK506 Binding Proteins as Targets in Anticancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 9
Page: 651-656
Authors: Simona Romano, AnnaLaura Di Pace, Antonio Sorrentino, Rita Bisogni, Luigi Sivero and Maria Fiammetta Romano

“Antisurvival” Factor Treatment for Hormone Refractory Prostate Cancer: Secondary Hormonal Ablation Using Somatostatin Analogs

Journal: Current Cancer Therapy Reviews
Volume: 7,Issue: 1
Page: 56-64
Authors: David Schilling, Rainer Kufer, Stephan Kruck, Sandra Waalkes, Arnulf Stenzl, Markus A. Kuczyk and Axel S. Merseburger

Dasatinib: An Anti-Tumour Agent via Src Inhibition

Journal: Current Drug Targets
Volume: 12,Issue: 4
Page: 563-578
Authors: Antonio Gnoni, Ilaria Marech, Nicola Silvestris, Angelo Vacca and Vito Lorusso

Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 2
Page: 151-167
Authors: Silvia Paba, Roberto Frau, Sean C. Godar, Paola Devoto, Francesco Marrosu and Marco Bortolato

Angiogenin as a Molecular Target for the Treatment of Prostate Cancer

Journal: Current Cancer Therapy Reviews
Volume: 7,Issue: 2
Page: 83-90
Authors: Shuping Li, Soichiro Ibaragi and Guo-fu Hu

Cytotoxic Effect of the Red Beetroot (Beta vulgaris L.) Extract Compared to Doxorubicin (Adriamycin) in the Human Prostate (PC-3) and Breast (MCF-7) Cancer Cell Lines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 3
Page: 280-284
Authors: Govind J. Kapadia, Magnus A. Azuine, G. Subba Rao, Takanari Arai, Akira Iida and Harukuni Tokuda

Role of Second-Line Systemic Treatment Post-Docetaxel in Metastatic Castrate Resistant Prostate Cancer- Current Strategies and Future Directions

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 3
Page: 296-306
Authors: Jawaher Ansari, Syed A Hussain, Abdulla Alhasso, Rana Mahmood, Asif Ansari and John Glaholm

The ACE Insertion/Deletion Polymorphism and Risk of Cancer, a Review and Meta-Analysis of the Literature

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 4
Page: 421-430
Authors: R. Ruiter, L. E. Visser, C. M. Van Duijn and B. H.Ch. Stricker

Engagement of Renin-Angiotensin System in Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 4
Page: 442-450
Authors: H. Uemura, K. Hoshino and Y. Kubota

Post-Translational Modifications of PTEN and their Potential Therapeutic Implications

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 5
Page: 536-547
Authors: G. Singh and A. M. Chan

SPECT-CT and PET-CT in Oncology - An Overview

Journal: Current Medical Imaging Reviews
Volume: 7,Issue: 3
Page: 202-209
Authors: Sandip Basu and Abass Alavi

Deciphering the Role of Forkhead Transcription Factors in Cancer Therapy

Journal: Current Drug Targets
Volume: 12,Issue: 9
Page: 1284-1290
Authors: Jer-Yen Yang and Mien-Chie Hung

Cancer Multitarget Pharmacology in Prostate Tumors: Tyrosine Kinase Inhibitors and Beyond

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 19
Page: 2827-2835
Authors: M. Bologna, C. Vicentini, P. Muzi, G. Pace and A. Angelucci

Contemporary Role of Endocrine Treatment in Patients with Localized or Locally Advanced Prostate Cancer: A Review

Journal: Current Cancer Therapy Reviews
Volume: 7,Issue: 3
Page: 201-214
Authors: Vallejo Herrador J. and Martinez-Pineiro L.

Mouse Prostate Proteome Changes Induced by Oral Pentagalloylglucose Treatment Suggest Targets for Cancer Chemoprevention

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 7
Page: 787-798
Authors: J. Zhang, K. Nkhata, A. A. Shaik, L. Wang, L. Li, Y. Zhang, L. A. Higgins, K. H. Kim, J. D. Liao, C. Xing, S.-H. Kim and J. Lu

Androgen Receptor Cofactors in Prostate Cancer: Potential Therapeutic Targets of Castration-Resistant Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 7
Page: 870-881
Authors: Masaki Shiota, Akira Yokomizo, Naohiro Fujimoto and Seiji Naito

Focal Adhesion Kinase Controls Prostate Cancer Progression Via Intrinsic Kinase and Scaffolding Functions

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 7
Page: 607-616
Authors: Sheila Figel and Irwin H. Gelman

Active-Targeted Nanotherapy Strategies for Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 8
Page: 954-965
Authors: M. Katsogiannou, L. Peng, C. V. Catapano and P. Rocchi

Clinical Trial Update and Novel Therapeutic Approaches for Metastatic Prostate Cancer

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 29
Page: 4440-4453
Authors: R. Larsson, N. P. Mongan, M. Johansson, L. Shcherbina, P.-A. Abrahamsson, L. J. Gudas, O. Sterner and J. L. Persson

The HOX Genes Network in Uro-Genital Cancers: Mechanisms and Potential Therapeutic Implications

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 32
Page: 4872-4884
Authors: M. Cantile, R. Franco, G. Schiavo, A. Procino, L. Cindolo, G. Botti and C. Cillo

Insight to Physiology and Pathology of Zinc(II) Ions and Their Actions in Breast and Prostate Carcinoma

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 33
Page: 5041-5051
Authors: J. Gumulec, M. Masarik, S. Krizkova, V. Adam, J. Hubalek, J. Hrabeta, T. Eckschlager, M. Stiborova and R. Kizek

Aberrant DNA Methylation and Prostate Cancer

Journal: Current Genomics
Volume: 12,Issue: 7
Page: 486-505
Authors: Sunipa Majumdar, Eric Buckles, John Estrada and Shahriar Koochekpour

The Evolution of Vibration Sonoelastography

Journal: Current Medical Imaging Reviews
Volume: 7,Issue: 4
Page: 283-291
Authors: Kevin J. Parker

Plasmid DNA Gene Therapy by Electroporation: Principles and Recent Advances

Journal: Current Gene Therapy
Volume: 11,Issue: 6
Page: 447-456
Authors: Tatsufumi Murakami and Yoshihide Sunada

Computational Models for 5αR Inhibitors for Treatment of Prostate Cancer: Review of Previous Works and Screening of Natural Inhibitors of 5αR2

Journal: Current Computer-Aided Drug Design
Volume: 7,Issue: 4
Page: 231-237
Authors: Rajamani M. Jayadeepa and Surbhi Sharma

Design of Curcumin loaded Cellulose Nanoparticles for Prostate Cancer

Journal: Current Drug Metabolism
Volume: 13,Issue: 1
Page: 120-128
Authors: Murali Mohan Yallapu, Mitch Ray Dobberpuhl, Diane Michele Maher, Meena Jaggi and Subhash Chand Chauhan

Cancer Preventive Effects of Vitamin E

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 1
Page: 156-164
Authors: Sayori Wada

Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 2
Page: 102-113
Authors: Philippe Clezardin

Bisphosphonate Anticancer Activity in Prostate Cancer and Other Genitourinary Cancers

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 2
Page: 129-136
Authors: Fred Saad and Peter Mulders

Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 6
Page: 856-870
Authors: C. Barinka, C. Rojas, B. Slusher and M. Pomper

A Novel Lily-of-the-Valley Fragrance Contrast Agent for Magnetic Resonance and Fluorescence Imaging of Prostate Cancer Cells

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 2
Page: 373-377
Authors: Alexander Sturzu, Hartmut Echner, Uwe Klose, Sumbla Sheikh, Thomas Nagele, Christian Schwentner, Ulrike Ernemann and Stefan Heckl

Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 2
Page: 144-163
Authors: V. Jeet, P. J. Russell, N. D. Verma and A. Khatri

GCPII Variants, Paralogs and Orthologs

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 9
Page: 1316-1322
Authors: K. Hlouchova, V. Navratil, J. Tykvart, P. Sacha and J. Konvalinka

GCPII Imaging and Cancer

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 9
Page: 1346-1359
Authors: C. A. Foss, R. C. Mease, S. Y. Cho, H. J. Kim and M. G. Pomper

New Cathepsin D Inhibitorswith Hydroxyethylamine Isosteres: Preparation and Characterization

Journal: Medicinal Chemistry
Volume: 2,Issue: 1
Page: 27-38
Authors: S. E. Hatfield, W. E. Godwin, K. Sayyar, J. F. Lindley, A. W. Green, C. J. Trana, M. S. McConnell and R. M. McConnell

Curcumin is an Inhibitor of p300 Histone Acetylatransferase

Journal: Medicinal Chemistry
Volume: 2,Issue: 2
Page: 169-174
Authors: Len Neckers, Jane Trepel, Sunmin Lee, Eun-Joo Chung, Min-Jung Lee, Yun-Jin Jung and Monica G. Marcu

Inhibitory Effects of Bisphosphonates on the Proliferation of Human Ovarian Cancer Cell Lines and the Mechanism

Journal: Medicinal Chemistry
Volume: 2,Issue: 3
Page: 223-226
Authors: Hiroshi Seto, Tsunekazu Kita, Junko Hirata, Yoshihiro Kikuchi and Kazuya Kudoh

Inhibitors of Steroidal Cytochrome P450 Enzymes as Targets for Drug Development

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2,Issue: 1
Page: 31-58
Authors: Eckhard Baston and Frederic R. Leroux

Thalidomide Analogues as Anticancer Drugs

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2,Issue: 2
Page: 167-174
Authors: Jeanny B. Aragon-Ching, Haiqing Li, Erin R. Gardner and William D. Figg

Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 3
Page: 182-190
Authors: William C. Olson, Warren D.W. Heston and Ayyappan K. Rajasekaran

Relevance of the Neuropeptide Y System in the Biology of Cancer Progression

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 17
Page: 1682-1691
Authors: M. Ruscica, E. Dozio, M. Motta and P. Magni

Prostate-Apoptosis-Response-Gene-4: Biological Properties and their Potential Therapeutic Exploitation in Hematological Malignancies

Journal: Letters in Drug Design & Discovery
Volume: 2,Issue: 4
Page: 266-273
Authors: Simone Boehrer, Daniel Nowak, Dieter Hoelzer, Paris S. Mitrou and Kai Uwe Chow

Synthesis and in Vitro Anti-Proliferative Activity of Racemic Trifluoro-Casodex® (Bicalutamide)

Journal: Letters in Organic Chemistry
Volume: 2,Issue: 5
Page: 447-449
Authors: M. Sani, F. Viani, M. Binda, N. Zaffaroni and M. Zanda

Vitamin E and Prostate Cancer: Current Evidence and Future Directions

Journal: Current Nutrition & Food Science
Volume: 1,Issue: 1
Page: 53-61
Authors: Margaret E. Wright and Michael F. Leitzmann

Involvement of PI3K/Akt Pathway in Prostate Cancer - Potential Strategies for Developing Targeted Therapies

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 5,Issue: 12
Page: 1125-1132
Authors: Nicole Pommery and Jean-Pierre Henichart

Doxsaliform: A Novel N-Mannich Base Prodrug of a Doxorubicin Formaldehyde Conjugate

Journal: Letters in Drug Design & Discovery
Volume: 1,Issue: 3
Page: 247-255
Authors: P. S. Cogan, C. R. Fowler, G. C. Post and T. H. Koch

The Role of Neuropeptide Processing Enzymes in Endocrine (Prostate) Cancer: EC 3.4.24.15 (EP24.15)

Journal: Protein & Peptide Letters
Volume: 11,Issue: 5
Page: 471-478
Authors: Todd A. Swanson, Sandra I. Kim, Michael Myers, Amanda Pabon, Keith D. Philibert, Mina Wang and Marc J. Glucksman

The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology

Journal: Current Topics in Medicinal Chemistry
Volume: 4,Issue: 13
Page: 1431-1452
Authors: David W. Moskowitz and Frank E. Johnson

Steroid 5α-Reductase Inhibitors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 3,Issue: 3
Page: 225-237
Authors: Eugenio Flores, Eugene Bratoeff, Marisa Cabeza, Elena Ramirez, Alexandra Quiroz and Ivonne Heuze

The Androgen Receptor as Putative Therapeutic Target in Hormone-Refractory Prostate Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2,Issue: 3
Page: 203-211
Authors: Yukio Kageyama, Nobuhiko Hyochi, Kazunori Kihara and Hiroshi Sugiyama

Antitumor Activity of Titanocene Y in Xenografted PC3 Tumors in Mice

Journal: Letters in Drug Design & Discovery
Volume: 5,Issue: 2
Page: 141-144
Authors: Catherine M. Dowling, James Claffey, Sandra Cuffe, Iduna Fichtner, Clara Pampillon, Nigel J. Sweeney, Katja Strohfeldt, R. William G. Watson and Matthias Tacke

Photoprotective Carotenoids Lutein and Zeaxanthin: Their Role in AMD

Journal: Current Nutrition & Food Science
Volume: 4,Issue: 2
Page: 127-134
Authors: A. Afzal and M. Afzal

Signal Transduction Targets in Prostate Cancer

Journal: Current Signal Transduction Therapy
Volume: 3,Issue: 2
Page: 112-128
Authors: Hari K. Koul and Lakshmipathi Khandrika

Carotenoids and Prostate Cancer Risk

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8,Issue: 5
Page: 529-537
Authors: C. Y.F. Young, H.-Q. Yuan, M.-L. He and J.-Y. Zhang

Clinical Trials of Targeted Alpha Therapy for Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 3,Issue: 3
Page: 185-191
Authors: Barry J. Allen

The Transcription Factor ETS-1: Its Role in Tumour Development and Strategies for its Inhibition

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8,Issue: 11
Page: 1095-1105
Authors: Jens Claus Hahne, Ali Fuat Okuducu, Aygun Sahin, Veronique Fafeur, Serafim Kiriakidis and Nicolas Wernert

Microwave-Assisted Synthesis of Imido-Substituted 2-Chloro-1,4-naphthoquinone Derivatives and their Cytotoxic Activities on Three Human Prostate Cancer Cell Lines

Journal: Letters in Drug Design & Discovery
Volume: 5,Issue: 8
Page: 485-488
Authors: Solomon Berhe, Yasmine Kanaan, Robert L. Copeland Jr., Dwayne A. Wright, Leon H. Zalkow and Oladapo Bakare

New Approaches to Target the Androgen Receptor and STAT3 for Prostate Cancer Treatments

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9,Issue: 3
Page: 395-400
Authors: Meilan He and Charles Y.F. Young

A Novel Synthesis Method of Apogossypolone and its Antitumor Activity

Journal: Letters in Drug Design & Discovery
Volume: 6,Issue: 2
Page: 129-132
Authors: Yonghua Zhan and Guangfeng Jia

A Novel Approach to Anticancer Therapies: Peroxisome Proliferator Activator-Receptor-γ as a New Target Therapy in the Treatment of Human Urological Cancer

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9,Issue: 1
Page: 76-83
Authors: M. Matsuyama and R. Yoshimura

Discovery of Novel CYP17 Inhibitors for the Treatment of Prostate Cancer with Structure-Based Drug Design

Journal: Letters in Drug Design & Discovery
Volume: 6,Issue: 5
Page: 337-344
Authors: Pelin Armutlu, Muhuttin Emre Ozdemir, Sule Ozdas, Ibrahim Halil Kavakli and Metin Turkay

Design, Synthesis, Crystal Structure and Antitumor Activity of A New Ethyl 3-(quinazolin-4-ylamino)-1H-pyrrole-2-carboxylate Derivative

Journal: Letters in Drug Design & Discovery
Volume: 6,Issue: 7
Page: 538-541
Authors: Youguang Zheng, Xiaoqing Wu, Min Sun, Liuhai Feng, Mingdong Li and Min Ji

Administration of Human Umbilical Cord Blood Cells Produces Interleukin-10 (IL-10) in IL-10 Deficient Mice Without Immunosuppression

Journal: Current Stem Cell Research & Therapy
Volume: 5,Issue: 1
Page: 13-16
Authors: Brian A. McCarthy, Alluru S. Reddi, Kathleen M. Coakley, Steven M. Nguyen, Rasha R. Nayal, Mohammad Javdan, Santanu Paul and Norman Ende

Flavonoids: Recent Advances as Anticancer Drugs

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5,Issue: 2
Page: 152-164
Authors: Hai L. Liu, Wen B. Jiang and Meng X. Xie

Natural Products: Potential for Developing Phellodendron amurense Bark Extract for Prostate Cancer Management

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 10,Issue: 5
Page: 388-397
Authors: A.P. Kumar, H. Graham, C. Robson, I.M. Thompson and R. Ghosh

Role of Androgen Receptor in Prostate Cancer Cell Cycle Regulation: Interaction with Cell Cycle Regulatory Proteins and Enzymes of DNA Synthesis

Journal: Current Protein & Peptide Science
Volume: 11,Issue: 6
Page: 451-458
Authors: Arun Sivanandam, Shalini Murthy, Sahn-Ho Kim, Evelyn R. Barrack and G. Prem Veer Reddy

Radionuclide Based Imaging of Prostate Cancer

Journal: Current Topics in Medicinal Chemistry
Volume: 10,Issue: 16
Page: 1600-1616
Authors: Ronnie C. Mease

Estrone (E1) Based Esters as Potential Inhibitors of Type 3 17β- hydroxysteroid Dehydrogenase (17β-HSD3) in the Treatment of Hormone-Dependent Prostate Cancer

Journal: Letters in Drug Design & Discovery
Volume: 7,Issue: 9
Page: 650-656
Authors: Moniola S. Olusanjo and Sabbir Ahmed

Vitamin Bs, One Carbon Metabolism and Prostate Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 10,Issue: 14
Page: 1385-1392
Authors: K. V. Donkena, H. Yuan and C. Y.F. Young

Tubulin-Independent Tau in Alzheimers Disease and Cancer: Implications for Disease Pathogenesis and Treatment

Journal: Current Alzheimer Research
Volume: 7,Issue: 8
Page: 697-707
Authors: S. Souter and G. Lee

Update on Screening in Prostate Cancer Based on Recent Clinical Trials

Journal: Reviews on Recent Clinical Trials
Volume: 6,Issue: 1
Page: 7-15
Authors: Alessandro Sciarra, Susanna Cattarino, Stefano Salciccia, Alessandro Gentilucci, Andrea Alfarone, Gianna Mariotti, Michele Innocenzi and Vincenzo Gentile

Review of Chemoradiotherapy for High-Risk Prostate Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 6,Issue: 1
Page: 65-69
Authors: Nicholas Sanfilippo, Matthew E. Hardee and Jonathan Wallach

The Current Status of Cryotherapy and High-Intensity Focused UltraSound in the Treatment of Low-Grade Prostate Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 6,Issue: 2
Page: 171-176
Authors: Vassilis J. Siomos and Al Barqawi

Targeting IGF-I, IGFBPs and IGF-I Receptor System in Cancer: The Current and Future in Breast Cancer Therapy

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6,Issue: 2
Page: 166-177
Authors: Lathika Mohanraj and Youngman Oh

Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 11,Issue: 2
Page: 131-149
Authors: Maitreyee K. Jathal, Liqun Chen, Maria Mudryj and Paramita M. Ghosh

Role of Micronutrients: Boron and Molybdenum in Crops and in Human Health and Nutrition

Journal: Current Nutrition & Food Science
Volume: 7,Issue: 2
Page: 126-136
Authors: Umesh C. Gupta, Prakash C. Srivastava and Subhas C. Gupta

Synthesis and Cytotoxic Activity of New β-Carboline Derivatives

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11,Issue: 6
Page: 486-491
Authors: A. Peduto, V. More, P. de Caprariis, M. Festa, A. Capasso, S. Piacente, L. De Martino, V. De Feo and R. Filosa

Design, Synthesis of Novel Quinazolone Alkaloids Derivatives as Potential Antitumor Agents

Journal: Medicinal Chemistry
Volume: 7,Issue: 4
Page: 295-300
Authors: Youguang Zheng, Min Sun, Yi Liu, Mingdong Li and Min Ji

A Critical Systematic Review of Recent Clinical Trials Comparing Open Retropubic, Laparoscopic and Robot-Assisted Laparoscopic Radical Prostatectomy

Journal: Reviews on Recent Clinical Trials
Volume: 6,Issue: 3
Page: 241-249
Authors: R. Heer, I. Raymond, M. J. Jackson and N. A. Soomro

Targeting SP1 Transcription Factor in Prostate Cancer Therapy

Journal: Medicinal Chemistry
Volume: 7,Issue: 5
Page: 518-525
Authors: Umesh T. Sankpal, Steven Goodison, Maen Abdelrahim and Riyaz Basha

Therapeutic Targeting of TRP Channels - The TR(i)P to Pain Relief

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 17
Page: 2118-2130
Authors: Samer R. Eid

TRPM8 Biology and Medicinal Chemistry

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 17
Page: 2237-2252
Authors: Jeff DeFalco, Matthew A.J. Duncton and Daniel Emerling

New Therapeutic Strategies for Castration-Resistant Prostate Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6,Issue: 3
Page: 373-383
Authors: Tomoaki Tanaka and Tatsuya Nakatani

Prostate Cancer with Variants in CYP17 and UGT2B17 Genes: A Meta-Analysis

Journal: Protein & Peptide Letters
Volume: 19,Issue: 1
Page: 62-69
Authors: Lai Cai, Wei Huang and Kuo-Chen Chou

Manipulating the Ability of Substituted Titanocene Derivatives to Induce Apoptosis in Castrate-Resistant Prostate Cancer Cells

Journal: Letters in Drug Design & Discovery
Volume: 9,Issue: 3
Page: 226-233
Authors: Catherine M. Dowling, Sandra Cuffe, Matthias Tacke, Anthony Deally, Megan Hogan, John M. Fitzpatrick and R. William G. Watson

Current Drug Therapy for Prostate Cancer: An Overview

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 5,Issue: 6
Page: 603-612
Authors: A. B. Stewart, B. A. Lwaleed, D. A. Douglas and B. R. Birch

The Utility of Proteomic Patterns for the Diagnosis of Cancer

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 4,Issue: 1
Page: 41-50
Authors: Thomas P. Conrads and Timothy D. Veenstra

Evidence for a Putative Relationship Between Type 2 Diabetes and Neoplasia with Particular Reference to Breast Cancer: Role of Hormones, Growth Factors and Specific Receptors

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 4,Issue: 1
Page: 59-66
Authors: E. Guastamacchia, F. Resta, V. Triggiani, A. Liso, B. Licchelli, S. Ghiyasaldin, C. Sabba and E. Tafaro

Can PPARγ Ligands Be Used in Cancer Therapy?

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 4,Issue: 6
Page: 465-477
Authors: M. A.K. Rumi, S. Ishihara, H. Kazumori, Y. Kadowaki and Y. Kinoshita

Aromatase Inhibitors: A New Paradigm in Breast Cancer Treatment

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 4,Issue: 6
Page: 523-534
Authors: J. Narashimamurthy, A. Raghu Ram Rao and G. Narahari Sastry

The BCL2-Family of Protein Ligands as Cancer Drugs: The Next Generation of Therapeutics

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3,Issue: 3
Page: 217-223
Authors: WenJing Liu, Anca Bulgaru, Missak Haigentz, C. A. Stein, Roman Perez-Soler and Sridhar Mani

Prostate Cancer Horizons in the Development of Novel Anti-Cancer Strategies

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 1,Issue: 1
Page: 47-70
Authors: A. G. Papatsoris and A. G. Papavassiliou

Aberrant Activation of Arachidonic Acid and Eicosanoid Pathways-Targets for Treating Prostate Cancer

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 2,Issue: 1
Page: 9-15
Authors: Qihan Dong, Marzieh Niknami, Manish Patel and Paul Witting

The Role of Chromogranin A (CgA) in Monitoring Patients with Prostate Cancer Under Androgen Deprivation Therapy: Comparison with Prostatic Specific Antigen (PSA)

Journal: Current Radiopharmaceuticals
Volume: 1,Issue: 2
Page: 115-119
Authors: Athanasios Bantis, Petros Sountoulides, Athanasios Zissimopoulos, Christos Kalaitzis, Stilianos Giannakopoulos, Eleni Agelonidou, Thrasivoulos Pantazis and Stavros Touloupidis

Supramolecular Chiro-Biomedical Assays and Enantioselective HPLC Analyses for Evaluation of Profens as Non-Steroidal Anti-Inflammatory Drugs, Potential Anticancer Agents and Common Xenobiotics

Journal: Current Drug Discovery Technologies
Volume: 5,Issue: 2
Page: 105-120
Authors: Imran Ali, Iqbal Hussain, Kishwar Saleem, Hassan Y. Aboul-Enein and Grzegorz Bazylak

Current Advances in Antibody Immobilization on Different Surfaces and Beads

Journal: Current Proteomics
Volume: 5,Issue: 2
Page: 115-128
Authors: Hans W. Hahn, Rania Bakry, Christian W. Huck, Matthias Rainer, Muhammad Najam-ul-Haq and Gunther K. Bonn

Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy

Journal: Current Radiopharmaceuticals
Volume: 1,Issue: 3
Page: 203-208
Authors: Oyvind S. Bruland, Thora J. Jonasdottir, Darrell R. Fisher and Roy H. Larsen

Targeted α-Particle Therapy: A Clinical Overview

Journal: Current Radiopharmaceuticals
Volume: 1,Issue: 3
Page: 251-253
Authors: Massimo Salvatori, Luca Indovina and Luigi Mansi

Preclinical Evaluation of a Monoclonal Antibody (3C6) Specific for Prostate-Specific Membrane Antigen

Journal: Current Radiopharmaceuticals
Volume: 2,Issue: 1
Page: 9-17
Authors: C. A.S. Regino, K. J. Wong, D. E. Milenic, E. H. Holmes, K. Garmestani, P. L. Choyke and M. W. Brechbiel

VEGF Inhibitors and Prostate Cancer Therapy

Journal: Current Molecular Pharmacology
Volume: 2,Issue: 2
Page: 161-168
Authors: Jeanny B. Aragon-Ching and William L. Dahut

Potential Clinical Applications of (-), (+) and (±)-Z-Bisdehydrodoisynolic Acids in Metabolic Disorders

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 3,Issue: 3
Page: 173-178
Authors: Jeremy E. Davis, Yuqing Hou, Cal Y. Meyers and William J. Banz

Prostate Cancer Gene Expression Marker 1 (PCGEM1): A Patented Prostate- Specific Non-Coding Gene and Regulator of Prostate Cancer Progression

Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 3,Issue: 3
Page: 151-163
Authors: Godwin O. Ifere and Godwin A. Ananaba

Hypoxia in DU-145 Prostate Cancer Xenografts after Estramustine Phosphate and Radiotherapy

Journal: Current Radiopharmaceuticals
Volume: 3,Issue: 1
Page: 19-24
Authors: Kaarlo Stahlberg, Eeva-Liisa Kamarainen, Jan Keyrilainen, Ismo Virtanen, Kimmo Taari and Kalevi Kairemo

Hypoxia in Du-145 Prostate Cancer Xenografts After Estramustine Phosphate and Radiotherapy

Journal: Current Radiopharmaceuticals
Volume: 3,Issue: 4
Page: 297-303
Authors: Kaarlo Stahlberg, Eeva-Liisa Kamarainen, Jan Keyrilainen, Ismo Virtanen, Kimmo Taari and Kalevi Kairemo

In Vitro and In Vivo Biodistribution of ZRS1, a Stabilized Type I N-Acetoxymethyl Carbamate-Containing Combi-Molecule

Journal: Drug Metabolism Letters
Volume: 5,Issue: 2
Page: 141-149
Authors: Nahid Golabi, Zakaria Rachid, Qiyu Qiu, Ying Huang and Bertrand J. Jean-Claude

Melatonin, Immune Function and Cancer

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 5,Issue: 2
Page: 109-123
Authors: Venkatramanujam Srinivasan, Seithikurippu R. Pandi-Perumal, Amnon Brzezinski, Kunwar P. Bhatnagar and Daniel P. Cardinali

Pre-Clinical and Clinical Aspects of Peptide-based Vaccine Against Human Solid Tumors

Journal: Recent Patents on Biotechnology
Volume: 5,Issue: 2
Page: 108-117
Authors: Seyed Amir Jalali and Giorgio Parmiani

Alpha-1-Adrenergic Receptor Blockade Modifies Insulin-Regulated Aminopeptidase (IRAP) Activity in Rat Prostate and Modulates Oxytocin Functions

Journal: Drug Metabolism Letters
Volume: 5,Issue: 3
Page: 192-196
Authors: Marcela Arrazola Saniger, Maria Jesus Ramirez-Exposito, Susana de la Chica, Maria Pilar Carrera-Gonzalez, Maria Dolores Mayas and Jose Manuel Martinez-Martos

SENP1 as A Biomarker for the Diagnosis of Cancer: Review of the Science and Published Patents

Journal: Recent Patents on Biomarkers (Discontinued)
Volume: 2,Issue: 1
Page: 29-35
Authors: Jacinta Uzoigwe and Edward R. Sauter

Systems Biology and Personalized Medicine in Cancer

Journal: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)
Volume: 8,Issue: 1
Page: 64-72
Authors: K. Mani

Pancreatic Cancer and Personalized Medicine: Can Genomics Facilitate Early Diagnosis or Improve Therapeutic Outcomes?

Journal: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)
Volume: 8,Issue: 1
Page: 73-88
Authors: A. S. Strimpakos, C. Hoimes, K. N. Syrigos and M. W. Saif

Cancer Vaccines: Personalizing Health Interventions

Journal: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)
Volume: 9,Issue: 3
Page: 208-228
Authors: Chandan Thomas and Majid Moridani

ATP Citrate Lyase Inhibitors as Novel Cancer Therapeutic Agents

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 7,Issue: 2
Page: 154-167
Authors: Xu-Yu Zu, Qing-Hai Zhang, Jiang-Hua Liu, Ren-Xian Cao, Jing Zhong, Guang-Hui Yi, Zhi-Hua Quan and Giuseppe Pizzorno

Prostate Cancer Prevention in the Developing World - What are we Waiting for?

Journal: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)
Volume: 10,Issue: 1
Page: 70-86
Authors: Karen S. Bishop, Chi Hsiu-Juei Kao, Dug Yeo Han and Lynnette R. Ferguson

Tissue Biomarkers for Prostate Cancer Radiation Therapy

Journal: Current Molecular Medicine
Volume: 12,Issue: 6
Page: 772-787
Authors: P. T. Tran, R. K. Hales, J. Zeng, K. Aziz, T. Salih, R. P. Gajula, S. Chettiar, N. Gandhi, A. T. Wild, R. Kumar, J. M. Herman, D. Y. Song and T. L. DeWeese

Overcoming Drug Resistance and Treating Advanced Prostate Cancer

Journal: Current Drug Targets
Volume: 13,Issue: 10
Page: 1308-1323
Authors: Julius Semenas, Cinzia Allegrucci, Stephen A. Boorjian, Nigel P. Mongan and Jenny Liao Persson

Anti-Tumor Effect of AlkB Homolog 3 Knockdown in Hormone- Independent Prostate Cancer Cells

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 7
Page: 847-856
Authors: K. Koike, Y. Ueda, H. Hase, K. Kitae, Y. Fusamae, S. Masai, T. Inagaki, Y. Saigo, S. Hirasawa, K. Nakajima, I. Ohshio, Y. Makino, N. Konishi, H. Yamamoto and K. Tsujikawa

Myogenic Differentiation of Mesenchymal Stem Cells is Induced by Striated Muscle Influences in vitro

Journal: Current Signal Transduction Therapy
Volume: 7,Issue: 3
Page: 220-227
Authors: Anna Bajek, Tomasz Drewa, Romana Joachimiak, Zaneta Spoz, Maciej Gagat, Magdalena Bodnar, Robert Debski, Alina Grzanka and Andrzej Marszalek

Effect of Hyperthermia and Triblock Copolymeric Nanoparticles as Quercetin Carrier on DU145 Prostate Cancer Cells

Journal: Current Nanoscience
Volume: 8,Issue: 5
Page: 690-696
Authors: Samideh Khoei, Maryam Azarian and Sepideh Khoee

Perspectives on mTOR Inhibitors for Castration-Refractory Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 8
Page: 940-949
Authors: Salvatore L. Burgio, Francesco Fabbri, Ian J. Seymour, Wainer Zoli, Dino Amadori and Ugo De Giorgi

Novel Antitumor Strategies Using Cytokine PEDF for Prostate Cancer Therapy

Journal: Current Angiogenesis (Discontinued)
Volume: 1,Issue: 4
Page: 277-298
Authors: Olga Zolochevska, Sofia H. Bergstrom, Brennen Comeaux, Todd Emrick and Marxa L. Figueiredo

Calcium Channels and Prostate Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 8,Issue: 1
Page: 18-26
Authors: George Shapovalov, Roman Skryma and Natalia Prevarskaya

Editorial: Prostate Cancer Immunotherapy

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 4
Page: 237-237
Authors: Dr. Dev Karan and Peter Van Veldhuizen

Approaches Used in Immunotherapy for Prostate Cancer

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 4
Page: 238-244
Authors: Guru Sonpavde

DNA Vaccines for Prostate Cancer

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 4
Page: 245-253
Authors: Douglas G. McNeel, Jordan T. Becker, Laura E. Johnson and Brian M. Olson

Immune Response and Immunotherapy: Live Attenuated Listeria monocytogenes (Lm)-LLO Immunotherapy for the Treatment of Prostate Cancer

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 4
Page: 254-263
Authors: Anu Wallecha, Robert Petit, Chris French and John Rothman

Adenovirus-based Immunotherapy for Prostate Cancer

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 4
Page: 264-270
Authors: Seema Dubey, Peter VanVeldhuizen and Dev Karan

Adenovirus/PSA (Ad5-PSA) Vaccination for Prostate Cancer: Pre-Clinical and Clinical Development

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 4
Page: 271-273
Authors: Daniel Vaena and David Lubaroff

Prostate Cancer Immunotherapy: An Evolving Field

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 4
Page: 274-282
Authors: Mehmood Hashmi, Dev Karan, Sneha Phadke, Yogen Saunthararajah, Suman Kambhampati and Peter Van Veldhuizen

Vitamin D, Sunlight, and the Epidemiology of Prostate Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 45-57
Authors: Gary G. Schwartz

Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 1
Page: 144-157
Authors: J. Dulinska-Litewka, J.A. McCubrey and P. Laidler

NADPH Oxidases NOXs and DUOXs as Putative Targets for Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 3
Page: 502-514
Authors: Urbain Weyemi, Christophe E. Redon, Palak R. Parekh, Corinne Dupuy and William M. Bonner

A Sample Selection Strategy to Boost the Statistical Power of Signature Detection in Cancer Expression Profile Studies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 2
Page: 203-211
Authors: Zhenyu Jia, Yipeng Wang, Yuanjie Hu, Christine McLaren, Yingyan Yu, Kai Ye, Xiao-Qin Xia, James A. Koziol, Waldemar Lernhardt, Michael McClelland and Dan Mercola

Prostate Cancer, miRNAs, Metallothioneins and Resistance to Cytostatic Drugs

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 4
Page: 534-544
Authors: V. Pekarik, J. Gumulec, M. Masarik, R. Kizek and V. Adam

Past, Present and Future of Nutrigenomics and its Influence on Drug Development

Journal: Current Drug Discovery Technologies
Volume: 10,Issue: 1
Page: 35-46
Authors: Kenneth Lundstrom

Estrogen Receptor Expression and its Relevant Signaling Pathway in Prostate Cancer: A Target of Therapy

Journal: Current Molecular Pharmacology
Volume: 5,Issue: 3
Page: 392-400
Authors: Yasuhiro Nakamura, Keely M McNamara and Hironobu Sasano

Anti-cancer Scopes and Associated Mechanisms of Scutellaria Extract and Flavonoid Wogonin

Journal: Current Cancer Therapy Reviews
Volume: 9,Issue: 1
Page: 34-42
Authors: Paras S. Patel, Nirmal Joshee, Agnes M. Rimando and Prahlad Parajuli

The PI3 Kinase Signaling Pathway in Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 2
Page: 157-164
Authors: Aymen A. Elfiky and Zhenyang Jiang

MicroRNA-Mediated Control of Prostate Cancer Metastasis: Implications for the Identification of Novel Biomarkers and Therapeutic Targets

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 12
Page: 1566-1584
Authors: Nicola Fenderico, Anna Casamichele, Valentina Profumo, Nadia Zaffaroni and Paolo Gandellini

Ellagic Acid: Cytodifferentiating and Antiproliferative Effects In Human Prostatic Cancer Cell Lines

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 15
Page: 2728-2736
Authors: Luca Vanella, Ignazio Barbagallo, Rosaria Acquaviva, Claudia Di Giacomo, Venera Cardile, Nader G. Abraham and Valeria Sorrenti

Targeted Radiosensitization in Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 15
Page: 2819-2828
Authors: Veerander P.S. Ghotra, Albert A. Geldof and Erik H.J. Danen

Editorial (Hot Topic: Androgen Receptor and Prostate Cancer: New Insights in an Old Target Translate into Novel Therapeutic Strategies)

Journal: Current Drug Targets
Volume: 14,Issue: 4
Page: 399-400
Authors: Hannelore V. Heemers

Androgen Receptor: Past, Present and Future

Journal: Current Drug Targets
Volume: 14,Issue: 4
Page: 401-407
Authors: Lucy J. Schmidt and Donald J. Tindall

Improved Therapeutic Targeting of the Androgen Receptor: Rational Drug Design Improves Survival in Castration-Resistant Prostate Cancer

Journal: Current Drug Targets
Volume: 14,Issue: 4
Page: 408-419
Authors: Ai Chiin Lim and Gerhardt Attard

The Role of Intracrine Androgen Metabolism, Androgen Receptor and Apoptosis in the Survival and Recurrence of Prostate Cancer During Androgen Deprivation Therapy

Journal: Current Drug Targets
Volume: 14,Issue: 4
Page: 420-440
Authors: Michael V. Fiandalo, Wenjie Wu and James L. Mohler

Androgen Receptor Gene Rearrangements: New Perspectives on Prostate Cancer Progression

Journal: Current Drug Targets
Volume: 14,Issue: 4
Page: 441-449
Authors: Lucas J. Brand and Scott M. Dehm

Recurrent Rearrangements in Prostate Cancer: Causes and Therapeutic Potential

Journal: Current Drug Targets
Volume: 14,Issue: 4
Page: 450-459
Authors: Nicole M. White, Felix Y. Feng and Christopher A. Maher

The Role of Tumor Suppressor Dysregulation in Prostate Cancer Progression

Journal: Current Drug Targets
Volume: 14,Issue: 4
Page: 460-471
Authors: Jeffry L. Dean and Karen E. Knudsen

Genome-Wide Integrated Analyses of Androgen Receptor Signaling in Prostate Cancer Based on High-Throughput Technology

Journal: Current Drug Targets
Volume: 14,Issue: 4
Page: 472-480
Authors: Kuniko Horie-Inoue and Satoshi Inoue

Identification of a RhoA- and SRF-Dependent Mechanism of Androgen Action that is Associated with Prostate Cancer Progression

Journal: Current Drug Targets
Volume: 14,Issue: 4
Page: 481-489
Authors: Hannelore V. Heemers

Androgen Pathway Related Gene Variants and Prostate Cancer Association in Auckland Men

Journal: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)
Volume: 11,Issue: 1
Page: 22-30
Authors: Nishi Karunasinghe, Katja Lange, Dug Yeo Han, Megan Goudie, Shuotun Zhu, Alice H. Wang, Karen Bishop, Lynnette R. Ferguson and Jonathan G. Masters

Understanding and Targeting Osteoclastic Activity in Prostate Cancer Bone Metastases

Journal: Current Molecular Medicine
Volume: 13,Issue: 4
Page: 626-639
Authors: J.L. Sottnik and E.T. Keller

Cabazitaxel: A Novel Drug for Hormone-Refractory Prostate Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13,Issue: 6
Page: 915-920
Authors: Manav Malhotra, Richa Dhingra, Tina Sharma, Aakash Deep, Balasubramanian Narasimhan, Priyanka Phogat and Prabodh Chander Sharma

An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 18
Page: 3329-3341
Authors: Zilin Yu, Hildo J. K. Ananias, Giuseppe Carlucci, Hilde D. Hoving, Wijnand Helfrich, Rudi A.J.O. Dierckx, Fan Wang, Igle J. de Jong and Philip H. Elsinga

FRET Based Ratio-Metric Sensing of Hyaluronidase in Synthetic Urine as a Biomarker for Bladder and Prostate Cancer

Journal: Current Pharmaceutical Biotechnology
Volume: 14,Issue: 4
Page: 470-474
Authors: Rahul Chib, Sangram Raut, Rafal Fudala, Aaron Chang, Mark Mummert, Ryan Rich, Zygmunt Gryczynski and Ignacy Gryczynski

Microbubble-Assisted p53, RB, and p130 Gene Transfer in Combination with Radiation Therapy in Prostate Cancer

Journal: Current Gene Therapy
Volume: 13,Issue: 3
Page: 163-174
Authors: Rounak Nande, Adelaide Greco, Michael S. Gossman, Jeffrey P. Lopez, Luigi Claudio, Marco Salvatore, Arturo Brunetti, James Denvir, Candace M. Howard and Pier Paolo Claudio

Fluorine-18 Labeled Amino Acids for Oncologic Imaging with Positron Emission Tomography

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 8
Page: 871-891
Authors: Chaofeng Huang and Jonathan McConathy

PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 8
Page: 951-962
Authors: Ronnie C. Mease, Catherine A. Foss and Martin G. Pomper

Castration-resistant Prostate Cancer: Novel Therapeutics Pre- or Post- Taxane Administration

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 4
Page: 444-459
Authors: Masaki Shiota, Akira Yokomizo, Naohiro Fujimoto, Hidetoshi Kuruma and Seiji Naito

Targeting the Fibroblast Growth Factor Receptors for the Treatment of Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 5
Page: 748-761
Authors: Steven M. Lemieux and M. Kyle Hadden

Computational and Functional Analysis of the Androgen Receptor Antagonist Atraric Acid and Its Derivatives

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 5
Page: 801-810
Authors: Maria Papaioannou, Annu A. Soderholm, Wei Hong, Yifan Dai, Julia Roediger, Daniela Roell, Marie Thiele, Tommi H. Nyronen and Aria Baniahmad

CDK Inhibitors Induce Mitochondria-mediated Apoptosis Through the Activation of Polyamine Catabolic Pathway in LNCaP, DU145 and PC3 Prostate Cancer Cells

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 2
Page: 180-188
Authors: Elif Damla Arisan, Pinar Obakan, Ajda Coker-Gurkan, Annarica Calcabrini, Enzo Agostinelli and Narcin Palavan Unsal

Castration Resistant Prostate Cancer: From Emerging Molecular Pathways to Targeted Therapeutic Approaches

Journal: Clinical Cancer Drugs
Volume: 1,Issue: 1
Page: 11-27
Authors: Patrizia Limonta, Roberta M. Moretti, Monica Marzagalli and Marina Montagnani Marelli

A Challenge for Medicinal Chemistry by the 17β-hydroxysteroid Dehydrogenase Superfamily: An Integrated Biological Function and Inhibition Study

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 10
Page: 1164-1171
Authors: S.-X. Lin, D. Poirier and J. Adamski

Osteoporosis in Patients with Breast and Prostate Cancer: Effect of Disease and Treatment Modalities

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 13,Issue: 2
Page: 168-174
Authors: Ioannis Legakis and Konstantinos Syrigos

Castration Resistant Prostate Cancer (CRPC): State of the Art, Perspectives and New Challenges

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 6
Page: 872-886
Authors: Francesco Massari, Francesca Maines, Alessandra Modena, Matteo Brunelli, Emilio Bria, Walter Artibani, Guido Martignoni and Giampaolo Tortora

Sugar-Borate Esters – Potential Chemical Agents in Prostate Cancer Chemoprevention

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 6
Page: 901-909
Authors: Romulus Ion Scorei and Radu Popa

Targeting Heat Shock Proteins in Prostate Cancer

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 22
Page: 2731-2740
Authors: W. Hessenkemper and A. Baniahmad

β2-Microglobulin-mediated Signaling as a Target for Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 3
Page: 343-352
Authors: Takeo Nomura, Wen-Chin Huang, Haiyen E. Zhau, Sajni Josson, Hiromitsu Mimata and Leland W. K. Chung

Cancer T Cell Immunotherapy with Bispecific Antibodies and Chimeric Antigen Receptors

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 8,Issue: 3
Page: 239-254
Authors: Markus D. Lacher and Maurizio Provenzano

The Dilemma of Localizing Disease Relapse After Radical Treatment for Prostate Cancer: Which is the Value of the Actual Imaging Techniques?

Journal: Current Radiopharmaceuticals
Volume: 6,Issue: 2
Page: 92-95
Authors: Schiavina R, Ceci F, Borghesi M, Brunocilla E, Vagnoni V, Gacci M, Castellucci P, Nanni C, Martorana G and Fanti S

Hydroxytyrosol Promotes Superoxide Production and Defects in Autophagy Leading to Anti-proliferation and Apoptosis on Human Prostate Cancer Cells

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 6
Page: 625-639
Authors: Cheng Luo, Yan Li, Hui Wang, Yang Cui, Zhihui Feng, Hua Li, Yuan Li, Ying Wang, Karin Wurtz, Peter Weber, Jiangang Long and Jiankang Liu

Evaluation of Tophaceous Gout by FDG-PET/CT and Bone Scan

Journal: Current Molecular Imaging (Discontinued)
Volume: 2,Issue: 2
Page: 117-119
Authors: Gottfried Wimmer, Simon W. Stoecklegger, Tatjana Stojakovic, Josef F. Hofer and Robert Pichler

Enzalutamide: A Novel Anti-androgen with Prolonged Survival Rate in CRPC Patients

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13,Issue: 10
Page: 1475-1486
Authors: Richa Dhingra, Tina Sharma, Sukhminder Singh, Shivani Sharma, Prince Tomar, Manav Malhotra and T.R. Bhardwaj

Anti-Tumoral Effect of the Non-Nucleoside DNMT Inhibitor RG108 in Human Prostate Cancer Cells

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 11
Page: 1803-1811
Authors: Ines Graca, Elsa J. Sousa, Tiago Baptista, Mafalda Almeida, Joao Ramalho-Carvalho, Carlos Palmeira, Rui Henrique and Carmen Jeronimo

Histone Modifications, Stem Cells and Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 11
Page: 1687-1697
Authors: Francesco Crea, Pier-Luc Clermont, Antonello Mai and Cheryl D. Helgason

Synthesis, Immunomodulation and Cytotoxic Effects of Vanadium (IV) Complexes

Journal: Medicinal Chemistry
Volume: 10,Issue: 3
Page: 287-299
Authors: Uzma Ashiq, Rifat Ara Jamal, Mohammad Ahmed Mesaik, Muhammad Mahroof-Tahir, Saba Shahid and Khalid Mohammed Khan

Androgen Receptor Antagonists in the Treatment of Prostate Cancer

Journal: Clinical Immunology, Endocrine & Metabolic Drugs
Volume: 1,Issue: 1
Page: 11-19
Authors: Takashi Kawahara and Hiroshi Miyamoto

S2SNet: A Tool for Transforming Characters and Numeric Sequences into Star Network Topological Indices in Chemoinformatics, Bioinformatics, Biomedical, and Social-Legal Sciences

Journal: Current Bioinformatics
Volume: 8,Issue: 4
Page: 429-437
Authors: Cristian R. Munteanu, Alexandre L. Magalhaes, Aliuska Duardo-Sanchez, Alejandro Pazos and Humberto Gonzalez-Diaz

Cytotoxic Effects of the Monomer and Dimer of 3, 4-seco-ent-kaurene from Croton Micans and their Interaction with Antitumoral Drugs on Cellular Line of Human Prostate Cancer

Journal: Letters in Drug Design & Discovery
Volume: 10,Issue: 8
Page: 683-688
Authors: Jennire Vivas, Felipe Sojo, Katiuska Chavez, Alírica I. Suarez and Francisco Arvelo

In Silico and Biochemical Analyses Identify Quinone Reductase 2 as a Target of Piceatannol

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 33
Page: 4195-4202
Authors: Tze-Chen Hsieh, Dylan John Bennett, Yong-Syu Lee, Erxi Wu and Joseph M. Wu

Potential Efficacy of Some African Plants in Benign Prostatic Hyperplasia and Prostate Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13,Issue: 11
Page: 1564-1571
Authors: Giorgio I. Russo, Sebastiano Cimino, Costanza Salamone, Massimo Madonia, Vincenzo Favilla, Tommaso Castelli and Giuseppe Morgia

The Effects of Bisphosphonates on the Bone Marrow Niche and Circulating and Disseminated Tumor Cells

Journal: Current Cancer Therapy Reviews
Volume: 9,Issue: 2
Page: 87-96
Authors: Rebecca L. Aft

Genetics, Structure, Function, Mode of Actions and Role in Cancer Development of CYP17

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 1
Page: 66-76
Authors: Tatyana. A Sushko, Andrei A. Gilep and Sergey A. Usanov

Cellomics as Integrative Omics for Cancer

Journal: Current Proteomics
Volume: 10,Issue: 3
Page: 237-245
Authors: Daniel Boda

Recent Patents of microRNAs as Biomarkers for Breast, Leukemia, Prostate and Cervical Cancers

Journal: Recent Patents on Biomarkers (Discontinued)
Volume: 3,Issue: 3
Page: 204-212
Authors: Mahmoud M. ElHefnawi, Sahar M. Ibrahim and Dina M. Ibrahim

Use of Insulin and Insulin Analogs and Risk of Cancer — Systematic Review and Meta-Analysis of Observational Studies

Journal: Current Drug Safety
Volume: 8,Issue: 5
Page: 333-348
Authors: Oystein Karlstad, Jacob Starup Linde, Peter Vestergaard, Vidar Hjellvik, Marloes T Bazelier, Marjanka K Schmidt, Morten Andersen, Anssi Auvinen, Jari Haukka, Kari Furu, Frank de Vries and Marie L De Bruin

PIM1 Kinase as a Target in Prostate Cancer: Roles in Tumorigenesis, Castration Resistance, and Docetaxel Resistance

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 2
Page: 105-114
Authors: Sheldon L. Holder and Sarki A. Abdulkadir

The Role of Neuroendocrine Cells in Prostate Cancer: A Comprehensive Review of Current Literature and Subsequent Rationale to Broaden and Integrate Current Treatment Modalities

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 9
Page: 1082-1092
Authors: F. Lugnani, G. Simone, P.M. Biava and R.J. Ablin

Id-1B, an Alternatively Spliced Isoform of the Inhibitor of Differentiation-1, Impairs Cancer Cell Malignancy Through Inhibition of Proliferation and Angiogenesis

Journal: Current Molecular Medicine
Volume: 14,Issue: 1
Page: 151-162
Authors: P. Nguewa, I. Manrique, R. Díaz, M. Redrado, R. Parrondo, C. Perez-Stable and A. Calvo

Downstream Carcinogenesis Signaling Pathways by Green Tea Polyphenols: A Translational Perspective of Chemoprevention and Treatment for Cancers

Journal: Current Drug Metabolism
Volume: 15,Issue: 1
Page: 14-22
Authors: Guohua Hu, Lei Zhang, Yefei Rong, Xiaoling Ni and Yihong Sun

Osteoporotic Fracture Healing: Potential Use of Medicinal Plants from the Tropics

Journal: Current Drug Targets
Volume: 14,Issue: 14
Page: 1651-1658
Authors: Mohd Azri Abdul Jalil, Ahmad Nazrun Shuid and Norliza Muhammad

Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy

Journal: Clinical Cancer Drugs
Volume: 1,Issue: 2
Page: 116-126
Authors: Annabelle Chow, Giulio Francia, Andrew Kouri, Christina Lee, John M. Ebos, Robert S. Kerbel and Urban Emmenegger

Synthesis and Biochemical Evaluation of a Range of 4-(n-alkanesulfonate) benzyl Imidazole-Based Compounds as Inhibitors of Rat Testicular 17α-hydroxylase/17,20-lyase (P45017α) in the Treatment of Hormone- Dependent Prostate Cancer

Journal: Letters in Drug Design & Discovery
Volume: 11,Issue: 8
Page: 1000-1009
Authors: Pallav S. Shah, Imran Shahid, Wai-Yee Lee, Caroline P. Owen and Sabbir Ahmed

Synthesis and Development of MSN-Gd3+-C595 as MR Imaging Contrast Agent for Prostate Cancer Cell Imaging

Journal: Current Molecular Imaging (Discontinued)
Volume: 3,Issue: 1
Page: 43-51
Authors: Bita Mehravi, Mehdi Mirzaei, Mehdi S. Ardestani, Massoud Amanlou, Haleh Soltanghoraee, Negar Ghalandarlaki and Seyed Amir Mohsen Ziaee

Associations of Body Mass Index and Obesity-Related Genetic Variants with Serum Metabolites

Journal: Current Metabolomics
Volume: 2,Issue: 1
Page: 27-36
Authors: Jitender Kumar, Robert Karlsson, Corey D. Broeckling, Mun-Gwan Hong, Jonathan A. Prince, Jessica E. Prenni, Erik Ingelsson and Fredrik Wiklund

Is it Possible to Reduce the Incident of Colorectal Cancer by Modifying Diet and Lifestyle?

Journal: Current Cancer Therapy Reviews
Volume: 9,Issue: 3
Page: 157-163
Authors: Pedro J. Tarraga Lopez, Juan Solera Albero and Jose Antonio Rodriguez-Montes

Recent Advances in Metabolic Profiling and Imaging of Prostate Cancer

Journal: Current Metabolomics
Volume: 2,Issue: 1
Page: 53-69
Authors: Roopa Thapar and Mark A. Titus

A Fluorescent Alkyllysophospholipid Analog Exhibits Selective Cytotoxicity Against the Hormone-Insensitive Prostate Cancer Cell Line PC3

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 4
Page: 528-538
Authors: Pranati Samadder, Hoe-Sup Byun, Robert Bittman and Gilbert Arthur

The Membrane-targeted Alkylphosphocholine Erufosine Interferes with Survival Signals from the Extracellular Matrix

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 4
Page: 578-591
Authors: Gretel Chometon, Federica Cappuccini, Aurelia Raducanu, Monique Aumailley and Verena Jendrossek

Trifluoroibuprofen Inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S), Reduces Cancer Cell Proliferation and Inhibits in vivo Tumor Growth in Aggressive Prostate Cancer Models

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 7
Page: 1031-1041
Authors: Claudio Festuccia, Giovanni Luca Gravina, Andrea Mancini, Paola Muzi, Ernesto Di Cesare, Ralph Kirk, Matthew Smith, Shaun Hughes, Robert Gibson, Lu-Yun Lian, Enrico Ricevuto and Andrew J. Carnell

Marine Derived Bioactive Compounds for Breast and Prostate Cancer Treatment: A Review

Journal: Current Bioactive Compounds
Volume: 10,Issue: 1
Page: 62-74
Authors: Senthilkumar Kalimuthu, Jayachandran Venkatesan and Se-Kwon Kim

Cancer Stem Cells in Prostate Cancer Chemoresistance

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 3
Page: 225-240
Authors: Jie Ni, Paul Cozzi, Jingli Hao, Wei Duan, Peter Graham, John Kearsley and Yong Li

PET Imaging with [68Ga]NOTA-RGD for Prostate Cancer: A Comparative Study with [18F]Fluorodeoxyglucose and [18F]Fluoroethylcholine

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 4
Page: 371-379
Authors: Ina Israel, Dominik Richter, Jochen Stritzker, Michaela van Ooschot, Ulrike Donat, Andreas K. Buck and Samuel Samnick

Targeting Drug-Resistant Prostate Cancer with Dual PI3K/mTOR Inhibition

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 26
Page: 3048-3056
Authors: K.D. Tang and Ming-Tat Ling

Diagnostic und Therapeutic Value of Cell-free Circulating DNA as a Non-invasive Biomarker in Patients with Prostate Cancer

Journal: Current Cancer Therapy Reviews
Volume: 9,Issue: 4
Page: 258-264
Authors: Stefan Latz, Stefan C. Muller and Jorg Ellinger

The Chance of Small Interfering RNAs as Eligible Candidates for a Personalized Treatment of Prostate Cancer

Journal: Current Pharmaceutical Biotechnology
Volume: 14,Issue: 13
Page: 1145-1154
Authors: Katharina Pietschke, Tobias Walker, Stefanie Krajewski, Julia Kurz, Stefan Aufderklamm, Christian Schwentner, Christian Schlensak, Arnulf Stenzl, Hans P. Wendel and Andrea Nolte

Predicting Cancer-Related MiRNAs Using Expression Profiles in Tumor Tissue

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 5
Page: 438-444
Authors: Hsiuying Wang

Targeting Hormonal Signaling Pathways in Castration Resistant Prostate Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 9,Issue: 3
Page: 267-285
Authors: Marilena Manea, Marina Montagnani Marelli, Roberta M. Moretti, Roberto Maggi, Monica Marzagalli and Patrizia Limonta

Intracellular Delivery of Tumor Antigenic Peptides in Biodegradablepolymer Adjuvant for Enhancing Cancer Immunotherapy

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 21
Page: 2357-2366
Authors: H. Li and W. Ma

The Effect of Lycopene on the PI3K/Akt Signalling Pathway in Prostate Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 6
Page: 800-805
Authors: Jiezhong Chen, Adam O’Donoghue, Yi-Fu Deng, Bing Zhang, Fanning Kent and Tim O’Hare

Novel Nor-Homo- and Spiro-Oxetan- Steroids Target the Human Androgen Receptor and Act as Antiandrogens

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 9
Page: 1156-1167
Authors: M. Thiele, S. Rabe, W. Hessenkemper, D. Roell, S. Bartsch, F. Kraft, T.E. Abraham, A.B. Houtsmuller, M.E. van Royen, A. Giannis and A. Baniahmad

A Steroidal Na+/K+ ATPase Inhibitor Triggers Pro-apoptotic Signaling and Induces Apoptosis in Prostate and Lung Tumor Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 8
Page: 1161-1168
Authors: Sabina Honisch, Saad Alkahtani, Michalis Kounenidakis, Guilai Liu, Saud Alarifi, Hamad Al-Yahya, Konstantinos Dimas, Abdullah A. AlKahtane, Kyriakos C. Prousis, Bader Al-Dahmash, Theodora Calogeropoulou, Konstantinos Alevizopoulos, Florian Lang and Christos Stournaras

SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 39
Page: 6182-6190
Authors: Jianguo Feng and Liling Tang

Recent Androgen Receptor Antagonists in Prostate Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 14,Issue: 8
Page: 655-663
Authors: Xufang Lu, Kang Dun, Yang Wang, Yong Yang, Qidong You and Zhiyu Li

Differential Role of Apoptosis and Autophagy Associated with Anticancer Effect of Lupulone (Hop β-Acid) Derivatives on Prostate Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 8
Page: 1169-1178
Authors: Petros X.E. Mouratidis, Kay W. Colston, Nicoletta Charolidi and Grisha Pirianov

microRNA-133: Expression, Function and Therapeutic Potential in Muscle Diseases and Cancer

Journal: Current Drug Targets
Volume: 15,Issue: 9
Page: 817-828
Authors: Hao Yu, Yinhui Lu, Zhaofa Li and Qizhao Wang

Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression

Journal: Current Protein & Peptide Science
Volume: 15,Issue: 7
Page: 732-737
Authors: Sonia Liberati, Maria B. Morelli, Consuelo Amantini, Matteo Santoni, Massimo Nabissi, Claudio Cardinali and Giorgio Santoni

Anti-Angiogenesis in the Treatment of Genito-Urinary Cancers: Last Updates

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 2
Page: 88-96
Authors: Fadi El Karak, Hampig Raphael Kourie, Ralph Chebib, Samer Tabchi, Alain Daher, Joseph Kattan and Marwan Ghosn

Editorial (Thematic Issue: Signalling Pathways in Anti-cancer Drug Resistance)

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 26
Page: 3007-3008
Authors: Chen Chen, Jiezhong Chen and Kong-Nan Zhao

Stereological Quantification of Blood and Lymph Microvessels in Prostate Cancer. Its Relevance for the Anti-angiogenetic Therapy

Journal: Current Cancer Therapy Reviews
Volume: 10,Issue: 1
Page: 1-12
Authors: Almudena Coloma, Javier Codesal, Ildefonso Ingelmo, Jesus Ruiz, Fernando Teba, Jose M. Pozuelo, Rosario Rodriguez and Luis Santamaria

Prospective Trial of an Herbal Formula BYSH and Saw Palmetto in Patients with Hormonal Refractory Prostate Cancer: A Pilot Study

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 8,Issue: 3
Page: 196-202
Authors: Anthony C.-F. Ng, K.-F. Cheng and P.-C. Leung

A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 37-47
Authors: Subhajit Roy, Bawneet K. Narang, Shiva K. Rastogi and Ravindra K. Rawal


Dietary Polyphenols for Prostate Cancer Therapy

Journal: Current Bioactive Compounds
Volume: 10,Issue: 2
Page: 76-111
Authors: Yan A. Ivanenkov, Nina V. Chufarova, Mark S. Veselov and Alexander G. Majouga

Emergence of Azole Therapy for Cancer Associated Fungal Infections and Their Potential Human Toxicity

Journal: The Natural Products Journal
Volume: 4,Issue: 2
Page: 153-158
Authors: Lesley R. Varughese, Sneha Choubey, Mukesh Yadav and Vikas Beniwal


Cystine Dimethyl Ester Induces Apoptosis Through Regulation of PKC-δ and PKC-ε in Prostate Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 217-227
Authors: Nilgun Gurbuz, Margaret A. Park, Paul Dent, Asim B. Abdel Mageed, Suresh C. Sikka and Asli Baykal

Hedgehog Signaling and Urological Cancers

Journal: Current Drug Targets
Volume: 16,Issue: 3
Page: 258-271
Authors: Katsumi Shigemura and Masato Fujisawa

Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 9
Page: 860-871
Authors: Rui Zhou, Zongliang Lu, Kai Liu, Jing Guo, Jie Liu, Yong Zhou, Jian Yang, Mantian Mi and Hongxia Xu

Morphologic and Molecular Backgrounds for Personalized Management of Genito-Urinary Cancers: An Overview

Journal: Current Drug Targets
Volume: 16,Issue: 2
Page: 96-102
Authors: Rodolfo Montironi, Matteo Santoni, Antonio Lopez-Beltran, Liang Cheng, Holger Moch and Marina Scarpelli

Role of Epithelial Mesenchymal Transition in Prostate Tumorigenesis

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 10
Page: 1240-1248
Authors: Mohammad Imran Khan, Abid Hamid, Vaqar Mustafa Adhami, Rahul K Lall and Hasan Mukhtar

Procyanidin B2 3,3″-di-O-gallate Inhibits Endothelial Cells Growth and Motility by Targeting VEGFR2 and Integrin Signaling Pathways

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 1
Page: 14-26
Authors: Rahul Kumar, Gagan Deep, Michael F. Wempe, Rajesh Agarwal and Chapla Agarwal

Molecular Foundations for Personalized Therapy in Prostate Cancer

Journal: Current Drug Targets
Volume: 16,Issue: 2
Page: 103-114
Authors: Kurt W. Fisher, Rodolfo Montironi, Antonio Lopez Beltran, Holger Moch, Lisha Wang, Marina Scarpelli, Sean R. Williamson, Michael O. Koch and Liang Cheng

Curcumin-Based Anti-Prostate Cancer Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 138-156
Authors: Qiao-Hong Chen

The Impact of the Emerging Genomics Data on the Management of Agerelated Phenotypes in the Context of Cellular Senescence

Journal: Current Drug Targets
Volume: 17,Issue: 4
Page: 428-438
Authors: Alberto Montesanto, Silvana Geracitano, Sabrina Garasto, Sergio Fusco, Fabrizia Lattanzio, Giuseppe Passarino and Andrea Corsonello

Discovery of Novel N-alkyl 4-anilinofuro[2,3-b]quinoline Derivatives (CIL-102 Derivatives) Against Castration-resistant Human Prostate Cancers

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 4
Page: 493-500
Authors: We-Fen Lo, Yu-Wei Chou, Chih-Hua Tseng, Yia-Huei Shiu, Yu-Wen Chen, Shyh-Chyun Yang, Yeh-Long Chen, Ming-Fong Lin and Cherng-Chyi Tzeng

Recent Patents on New Steroid Agents Targeting the Steroidogenesis for Endocrine Cancer Treatments

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 9,Issue: 1
Page: 15-23
Authors: Donald Poirier

Present, Emerging and Possible Future Biomarkers in Castration Resistant Prostate Cancer (CRPC)

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 3
Page: 243-255
Authors: Martin Boegemann, Andres-Jan Schrader, Laura-Maria Krabbe and Edwin Herrmann

New Testosterone Derivatives as Semi-Synthetic Anticancer Agents Against Prostate Cancer: Synthesis and Preliminary Biological Evaluation

Journal: Medicinal Chemistry
Volume: 11,Issue: 6
Page: 531-539
Authors: Nathalie Morin, Julie Bruneau, Sebastien Fortin, Kevin Brasseur, Valerie Leblanc, Eric Asselin and Gervais Berube

Multigene Methylation Biomarker Analysis in Prostate Cancer

Journal: Epigenetic Diagnosis & Therapy
Volume: 1,Issue: 1
Page: 19-27
Authors: Therese M. Murphy, Alexandra V. Tuzova, Colm J. O'Rourke, O'Meachair S, Catherine Greene, Linda Sullivan, John Thornhill, Ciara Barrett, Barbara Loftus, Thomas Lynch and Antoinette S. Perry

Ligustrazine Suppresses the Growth of HRPC Cells through the Inhibition of Cap- Dependent Translation Via Both the mTOR and the MEK/ERK Pathways

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 6
Page: 764-772
Authors: Jiaoyan Han, Jiao Song, Xiangyun Li, Ming Zhu, Wei Guo, Wei Xing, Rongshen Zhao, Xiao He, Xiaoping Liu, Shali Wang, Yunyun Li, Hong Huang and Xiang Xu

Dormant Circulating Tumor Cells in Prostate Cancer: Therapeutic, Clinical and Biological Implications

Journal: Current Drug Targets
Volume: 17,Issue: 6
Page: 693-701
Authors: Maria J. Alvarez-Cubero, Fernando Vázquez-Alonso, Ignacio Puche-Sanz, F. Gabriel Ortega, M. Martin-Prieto, José L. Garcia-Puche, Manrique Pascual-Geler, José A. Lorente, José M. Cozar-Olmo and Maria J. Serrano

177Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay

Journal: Current Radiopharmaceuticals
Volume: 9,Issue: 1
Page: 85-93
Authors: Henia Balter, Trindade Victoria, Terán Mariella, Gaudiano Javier, Ferrando Rodolfo, Paolino Andrea, Rodriguez Graciela, Hermida Juan, De Marco Eugenia and Oliver Patricia

Radioimmunotherapy of Metastatic Prostate Cancer with 177Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody

Journal: Current Radiopharmaceuticals
Volume: 9,Issue: 1
Page: 44-53
Authors: Shankar Vallabhajosula, Anastasia Nikolopoulou, Yuliya S. Jhanwar, Gurveen Kaur, Scott T. Tagawa, David M. Nanus, Neil H. Bander and Stanley J. Goldsmith

Plumbagin Nanoparticles Induce Dose and pH Dependent Toxicity on Prostate Cancer Cells.

Journal: Current Drug Delivery
Volume: 12,Issue: 6
Page: 709-716
Authors: Harikrishnan A. Nair, K. S. Snima, Ravindranath C. Kamath, Shantikumar V. Nair and Vinoth-Kumar Lakshmanan

Planning of External Beam Radiotherapy for Prostate Cancer Guided by PET/CT

Journal: Current Radiopharmaceuticals
Volume: 8,Issue: 1
Page: 19-31
Authors: Finn Edler von Eyben, Kalevi Kairemo, Timo Kiljunen and Timo Joensuu

MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs

Journal: Current Drug Targets
Volume: 17,Issue: 3
Page: 257-265
Authors: Marzia Pennati, Marco Folini, Paolo Gandellini and Nadia Zaffaroni

Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate Cancer

Journal: Current Pharmaceutical Biotechnology
Volume: 16,Issue: 6
Page: 553-563
Authors: Florencia Zalazar, Paola De Luca, Kevin Gardner, William D. Figg, Roberto Meiss, Raul G. Spallanzani, Pablo Vallecorsa, Belen Elguero, Javier Cotignola, Elba Vazquez and Adriana De Siervi

Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 5
Page: 394-405
Authors: Ryan Stuchbery, Natalie J. Kurganovs, Patrick J. McCoy, Colleen C. Nelson, Vanessa M. Hayes, Niall M. Corcoran and Christopher M. Hovens

PET/CT Dose Planning for Volumetric Modulated arc Radiation Therapy (VMAT) -Comparison with Conventional Approach in Advanced Prostate Cancer Patients

Journal: Current Radiopharmaceuticals
Volume: 8,Issue: 1
Page: 2-8
Authors: Kalevi Kairemo, Nigora Rasulova, Timo Kiljunen, Kaarina Partanen, Aki Kangasmaki and Timo Joensuu

Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer

Journal: Current Drug Targets
Volume: 17,Issue: 3
Page: 276-289
Authors: Pavlos Msaouel, Jose Nahun Galeas, Alejandro Recio Boiles, Ramiro Rancier Ruiz and Michael Koutsilieris

The Accomplices of NF-κB Lead to Radioresistance

Journal: Current Protein & Peptide Science
Volume: 16,Issue: 4
Page: 279-294
Authors: Miaomiao Bai, Xiaoxing Ma, Xiaolei Li, Xiaohui Wang, Qian Mei, Xiang Li, Zhiqiang Wu and Weidong Han

Silencing GPX3 Expression Promotes Tumor Metastasis in Human Thyroid Cancer

Journal: Current Protein & Peptide Science
Volume: 16,Issue: 4
Page: 316-321
Authors: Hua Zhao, Jingyi Li, Xin Li, Chao Han, Yi Zhang, Lili Zheng and Mingzhou Guo

Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 6
Page: 469-480
Authors: Lewis Quayle, Penelope D. Ottewell and Ingunn Holen

The Role of Diabetes in Molecular Pathogenesis of Cancer

Journal: Current Signal Transduction Therapy
Volume: 10,Issue: 1
Page: 10-16
Authors: Arthur Matyszewski, Anna M. Czarnecka, Piotr Korzen, Ilan J. Safir, Wojciech Kukwa and Cezary Szczylik

Experience with Androgen Deprivation Therapy for Prostate Cancer in Japan and Future Perspectives

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 4
Page: 314-326
Authors: Yasuhide Kitagawa, Satoru Ueno, Hiroyuki Konaka, Atsushi Mizokami, Shiro Hinotsu, Hideyuki Akaza and Mikio Namiki

Steroid Receptor-Associated Immunophilins: Candidates for Diverse Drug-Targeting Approaches in Disease

Journal: Current Molecular Pharmacology
Volume: 9,Issue: 1
Page: 66-95
Authors: Thomas Ratajczak

Prostate Cancer Imaging: A New Era in Diagnostic Approach

Journal: Recent Patents and Topics on Imaging (Discontinued)
Volume: 5,Issue: 1
Page: 13-18
Authors: Hishar Hassan, Fathinul F.A. Saad, Rosa M. Moresco, Claudio Rosetti and Abdul J. Nordin

Recent Advances in Clinical Immunology, Endocrine & Metabolic Drugs: An Editorial Overview

Journal: Clinical Immunology, Endocrine & Metabolic Drugs
Volume: 1,Issue: 2
Page: 61-62
Authors: Thea Magrone and Emilio Jirillo

A Novel Triazole Nucleoside Suppresses Prostate Cancer Cell Growth by Inhibiting Heat Shock Factor 1 and Androgen Receptor

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 10
Page: 1333-1340
Authors: Yi Xia, Menghua Wang, Eliana Beraldi, Mei Cong, Amina Zoubeidi, Martin Gleave and Ling Peng

A Review on Chemical Profile of Coumarins and their Therapeutic Role in the Treatment of Cancer

Journal: Current Drug Delivery
Volume: 13,Issue: 2
Page: 186-201
Authors: K. Venkata Sairam, B. M. Gurupadayya, R. S. Chandan, Dattatri K. Nagesha and B. Vishwanathan

AKT and cytosolic phospholipase A2α form a positive loop in prostate cancer cells

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 9
Page: 781-791
Authors: Sheng Hua, Soma Vignarajan, Mu Yao, Chanlu Xie, Paul Sved and Qihan Dong

A Potent Inhibitor of Steroid Sulfatase (EM-1913) Blocks Tumor Growth in Nude Mice (MCF-7 Xenograft)

Journal: Current Enzyme Inhibition
Volume: 11,Issue: 1
Page: 65-73
Authors: Donald Poirier, Jenny Roy, Rene Maltais and Diana Ayan

A New Era of Immunotherapy in Prostate Cancer

Journal: Current Molecular Pharmacology
Volume: 9,Issue: 3
Page: 217-225
Authors: Christopher Pizzola, Syed M. Rizvi and Monika Joshi

Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 3
Page: 206-211
Authors: Anthony B. Miller, Ronald Feld, Robert Fontana, John K. Gohagan, Ismail Jatoi, Walter Lawrence Jr., Amy Miller, Philip C. ProroK, Ashwani Rajput, Morris Sherman, Gilbert Welch, Patrick Wright, Susan Yurgalevitch and Peter Albertsen

Design, Synthesis and Biological Evaluation of Thiohydantoin Derivatives as Novel Anti-prostate Cancer Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 6
Page: 740-746
Authors: Jianzhen Liu, Bo Liu, Yongkui Jing and Guisen Zhao

A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 3
Page: 393-403
Authors: Farhad Shahsavar, Mahmood Bozorgmehr, Ebrahim Mirzadegan, Anita Abedi, Zohreh Mehri Lighvan, Fereshteh Mohammadi, Nasser Safari, Vahid Amani and Amir-Hassan Zarnani

An Overview of Current Screening and Management Approaches for Prostate Cancer

Journal: Current Drug Metabolism
Volume: 16,Issue: 8
Page: 713-718
Authors: Omar N. Akram, Gohar Mushtaq and Mohammad Amjad Kamal

Privileged 1,2,4-Oxadiazoles in Anticancer Drug Design: Novel 5- Aryloxymethyl-1,2,4-oxadiazole Leads for Prostate Cancer Therapy

Journal: Letters in Drug Design & Discovery
Volume: 13,Issue: 3
Page: 198-204
Authors: Alexey Lukin, Ruben Karapetian, Yan Ivanenkov and Mikhail Krasavin

Bio-Distribution, Imaging Protocols and Diagnostic Accuracy of PET with Tracers of Lipogenesis in Imaging Prostate Cancer: a Comparison between 11C-Choline, 18FFluoroethylcholine and 18F-Methylcholine

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 32
Page: 4738-4747
Authors: Ferdinando Calabria, Gianpasquale Gallo, Orazio Schillaci and Giuseppe Lucio Cascini

VEGF/VEGFR2 Autocrine Signaling Stimulates Metastasis in Prostate Cancer Cells

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 4
Page: 231-244
Authors: Matthew Migliozzi, Yasuhiro Hida, Meetu Seth, Graham Brown, Joanne Kwan, Silvia Coma, Dipak Panigrahy, Rosalyn M. Adam, Jacqueline Banyard, Akio Shimizu and Diane R. Bielenberg

A Combined Quantitative Structure-Activity Relationship Research of Quinolinone Derivatives as Androgen Receptor Antagonists

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 18,Issue: 9
Page: 834-845
Authors: Yuwei Wang, Fang Bai, Hong Cao, Jiazhong Li, Huanxiang Liu and Paola Gramatica

Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?

Journal: Current Drug Targets
Volume: 17,Issue: 3
Page: 311-320
Authors: Daniela Verzella, Mariafausta Fischietti, Daria Capece, Davide Vecchiotti, Filippo Del Vecchio, Germana Cicciarelli, Valentina Mastroiaco, Alessandra Tessitore, Edoardo Alesse and Francesca Zazzeroni

New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer

Journal: Current Drug Targets
Volume: 17,Issue: 3
Page: 290-302
Authors: Rita Assi, Sally Temraz, Ali Shamseddine and Deborah Mukherji

Current State of ERG as Biomarker in Prostatic Adenocarcinoma

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 8
Page: 643-651
Authors: Balazs Acs, Tibor Szarvas, Nora Szekely, Peter Nyirady and A. Marcell Szasz

Thapsigargin, Origin, Chemistry, Structure-Activity Relationships and Prodrug Development

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 38
Page: 5501-5517
Authors: Nhu Thi Quynh Doan and Soren Brogger Christensen

In vitro Evaluation of Gadolinium-Silica Mesoporous Nanoparticles- Monoclonal Antibody: Potential Nanoprobe for Prostate Cancer Cell Imaging

Journal: Current Molecular Imaging (Discontinued)
Volume: 4,Issue: 1
Page: 35-42
Authors: Negar Ghalandarlaki, Noorahmad Latifi, Mehdi Mirzaei, Mohammad T. Joghatei, Sepideh Safari, Khadijeh Ashtari and Bita Mehravi

Flavonoids with Therapeutic Potential in Prostate Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 10
Page: 1205-1229
Authors: Bao Vue, Sheng Zhang and Qiao-Hong Chen

Image-Guided Nanoparticle-Based siRNA Delivery for Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 31
Page: 4637-4656
Authors: Yong-Dong Kim, Tae-Eun Park, Bijay Singh, Sushila Maharjan, Kye-Soo Cho, Kyoung Pyo Park, Yun-Jaie Choi, Rohidas B. Arote and Chong-Su Cho

Metabolic Alterations in Renal and Prostate Cancer

Journal: Current Drug Metabolism
Volume: 17,Issue: 2
Page: 150-155
Authors: Chiara Ciccarese, Matteo Santoni, Francesco Massari, Alessandra Modena, Francesco Piva, Alessandro Conti, Roberta Mazzucchelli, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Giampaolo Tortora and Rodolfo Montironi

A New and Effective Approach to the Synthesis of Sulforaphane

Journal: Letters in Organic Chemistry
Volume: 13,Issue: 1
Page: 7-10
Authors: Duy-Viet Vo, Van-Dat Truong, Thanh-Dao Tran, Van-Thanh-Nhan Do, Ngoc-Tuan-Anh Pham and Khac-Minh Thai

Tannic Acid Inhibits Proliferation, Migration, Invasion of Prostate Cancer and Modulates Drug Metabolizing and Antioxidant Enzymes

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 6
Page: 781-789
Authors: Serdar Karakurt and Orhan Adali

Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: 177Lu-PSMA is Set to Redefine Prostate Cancer Treatment)

Journal: Current Radiopharmaceuticals
Volume: 9,Issue: 1
Page: 6-7
Authors: Ambikalmajan M.R. Pillai and Furn F. (Russ) Knapp

Prostate Cancer Molecular Background: The IGF-1Ec Story

Journal: Clinical Cancer Drugs
Volume: 3,Issue: 1
Page: 6-15
Authors: Armakolas Athanasios and Koutsilieris Michael

Castration-resistant Prostate Cancer: The Targeting of Bone Microenvironment-related Survival Factors For Prostate Cancer Cells

Journal: Clinical Cancer Drugs
Volume: 3,Issue: 1
Page: 16-22
Authors: Dimitrios Karamanolakis, Athanasios Armakolas and Michael Koutsilieris

Synthesis of Fluorine-18-Labelled Choline (18F-Fluorocholine): Towards an Early and Accurate Management of Prostate Cancer in Malaysia

Journal: Current Medical Imaging Reviews
Volume: 12,Issue: 1
Page: 67-74
Authors: Hishar Hassan, Suharzelim A. Baker, Khairul N. C. A. Halim, Jaleezah Idris, Fathinul F. A. Saad and Abdul J. Nordin

S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 5
Page: 455-465
Authors: Zongliang Lu, Rui Zhou, Ya Kong, Jiajia Wang, Wanyuan Xia, Jing Guo, Jie Liu, Hailan Sun, Kai Liu, Jian Yang, Mantian Mi and Hongxia Xu

Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

Journal: Clinical Cancer Drugs
Volume: 3,Issue: 1
Page: 23-35
Authors: Lavinia Casati, Fabio Celotti and Valeria Sibilia

Therapeutic Value of an Integrin Antagonist in Prostate Cancer

Journal: Current Drug Targets
Volume: 17,Issue: 3
Page: 321-327
Authors: Clément-Lacroix Philippe

Synthesis of Methotrexate Loaded Chitosan Nanoparticles and in vitro Evaluation of the Potential in Treatment of Prostate Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 8
Page: 1038-1042
Authors: Selvi Gunel Nur, Ozel Buket, Kipcak Sezgi, Aktan Cagdas, Akgun Cansu, Ak Guliz, Yilmaz Habibe, Biray Avci Cigir, Dodurga Yavuz and Hamarat Sanlier Senay

Optimal Sequencing of New Drugs in Metastatic Castration-Resistant Prostate Cancer: Dream or Reality?

Journal: Current Drug Targets
Volume: 17,Issue: 11
Page: 1301-1308
Authors: Orazio Caffo, Andrea Lunardi, Chiara Trentin, Francesca Maines, Antonello Veccia and Enzo Galligioni

Towards the Molecular Imaging of Prostate Cancer Biomarkers Using Protein-based MRI Contrast Agents

Journal: Current Protein & Peptide Science
Volume: 17,Issue: 6
Page: 519-533
Authors: Fan Pu, Shenghui Xue, Jingjuan Qiao, Anvi Patel and Jenny J. Yang

nMET, A New Target in Recurrent Cancer

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 7
Page: 572-578
Authors: Yingqiu Xie, Sholpan Istayeva, Zhanlin Chen, Tursonjan Tokay, Zhaxybay Zhumadilov, Denglong Wu, Gonzalo Hortelano and Jinfu Zhang

Mevalonate Pathway and Human Cancers

Journal: Current Molecular Pharmacology
Volume: 10,Issue: 2
Page: 77-85
Authors: Seyedeh Zahra Bathaie, Mahboobeh Ashrafi, Mahshid Azizian and Fuyuhiko Tamanoi

Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers

Journal: Current Molecular Pharmacology
Volume: 10,Issue: 2
Page: 86-114
Authors: Pooneh Mokarram, Javad Alizadeh, Vahid Razban, Mahdi Barazeh, Claudia Solomon and Soudabeh Kavousipour

Selection of Single Chain Antibody Fragments for Targeting Prostate Specific Membrane Antigen: A Comparison Between Cell-based and Antigen-based Approach

Journal: Protein & Peptide Letters
Volume: 23,Issue: 4
Page: 336-342
Authors: Javad Rezaei, Masoumeh RajabiBazl, Walead Ebrahimizadeh, Gholamreza Rafiei Dehbidi and Hossien Hosseini

Advancements in Non-steroidal Antiandrogens as Potential Therapeutic Agents for the Treatment of Prostate Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16,Issue: 7
Page: 531-546
Authors: Paranjeet Kaur and Gopal L. Khatik

The Utility of Chemotherapy in the Treatment of Metastatic Prostate Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 9
Page: 1166-1171
Authors: Kanika Gupta, Jacob Elkon, Ehab El-Bahesh and Jeanny B. Aragon-Ching

Pathophysiology of Metastatic Bone Disease and the Role of the Second Generation of Bisphosphonates: From Basic Science to Medicine

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 11
Page: 1546-1557
Authors: Reham F. Barghash and Wafaa M. Abdou

Editorial (Thematic Issue: New Drug Targets for Treatment of Recurrent/Metastatic Prostate Cancer)

Journal: Current Drug Targets
Volume: 17,Issue: 3
Page: 254-256
Authors: Claudio Festuccia, Paola Negri-Cesi and Giovanni Luca Gravina

Emerging Immunotargets and Immunotherapies in Prostate Cancer

Journal: Current Drug Targets
Volume: 17,Issue: 7
Page: 777-782
Authors: Rodolfo Montironi, Matteo Santoni, Valeria Sotte, Liang Cheng, Antonio Lopez-Beltran, Francesco Massari, Marc R. Matrana, Holger Moch, Rossana Berardi and Marina Scarpelli

Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer

Journal: Current Drug Targets
Volume: 17,Issue: 5
Page: 488-494
Authors: Jorg B. Engel, Hans-Rudolf Tinneberg, Ferenc G. Rick, Enniko Berkes and Andrew V. Schally

Performance and Effect of Automatic Contouring in Automatic Adaptive Planning for Prostate Cancer Volumetric Modulated Radiotherapy

Journal: Recent Patents and Topics on Imaging (Discontinued)
Volume: 5,Issue: 2
Page: 73-78
Authors: Xiaoqiang Li, Xuanfeng Ding, An Qin and Di Yan

Editorial (Thematic Issue: Novel Therapeutic Strategies for Castration-resistant Prostate Cancer: Update and Future Perspectives)

Journal: Clinical Cancer Drugs
Volume: 3,Issue: 1
Page: 2-5
Authors: Patrizia Limonta

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Journal: Clinical Cancer Drugs
Volume: 3,Issue: 1
Page: 36-62
Authors: Festuccia Claudio

Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 11
Page: 1385-1402
Authors: Alessandra Bosutti, Fabrizio Zanconati, Gabriele Grassi, Barbara Dapas, Sabina Passamonti and Bruna Scaggiante

Current Progresses and Trends in the Development of Progesterone Receptor Modulators

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 23
Page: 2507-2554
Authors: Wenlu Li, Xi Li, Bin Zhang, Chunmei Gao, Yuzong Chen and Yuyang Jiang

Systems Medicine Approaches to Improving Understanding, Treatment, and Clinical Management of Neuroendocrine Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 34
Page: 5234-5248
Authors: Kamlesh K. Yadav, Khader Shameer, Ben Readhead, Shalini S. Yadav, Li Li, Andrew Kasarskis, Ashutosh K. Tewari and Joel T. Dudley

Preparation and Evaluation of in vitro Self-assembling HSA Nanoparticles for Cabazitaxel

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 2
Page: 294-300
Authors: Na Qu, Yating Sun, Jing Xie and Lesheng Teng

Prostate-Specific G-Protein Coupled Receptor, an Emerging Biomarker Regulating Inflammation and Prostate Cancer Invasion

Journal: Current Molecular Medicine
Volume: 16,Issue: 6
Page: 526-532
Authors: M. Rodriguez, S. Siwko and M. Liu

In Silico Identification of Human miR 3654 and its Targets Revealed its Involvement in Prostate Cancer Progression

Journal: MicroRNA
Volume: 5,Issue: 2
Page: 140-145
Authors: Subramanian Saravanan, Villianur I.H. Islam, Krishnaraj Thirugnanasambantham and Durairaj Sekar

Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive Review

Journal: Current Drug Targets
Volume: 18,Issue: 11
Page: 1233-1249
Authors: Rohit R. Bhosale*, H. V. Gangadharappa, Umme Hani*, Riyaz Ali M. Osmani, Rudra Vaghela, P. K. Kulkarni and Venkata Sairam Koganti

Bioconversion of Isoflavones into Bioactive Equol: State of the Art

Journal: Recent Patents on Food, Nutrition & Agriculture
Volume: 8,Issue: 2
Page: 91-98
Authors: Danielle B. Lopes, Amanda R.A. de Avila, Livia D. de Queiros, Juliana A. Macedo and Gabriela A. Macedo

Targeted Nanosystems to Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 39
Page: 5962-5975
Authors: Luiz Cláudio Rodrigues Pereira da Silva, Flávia Almada do Carmoa, Luiz Eurico Nasciutti, Patrícia Zancan, Plínio Cunha Sathler and Lucio Mendes Cabral

Early Docetaxel and Androgen Deprivation in the Treatment of Metastatic, Hormone-sensitive Prostate Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 11,Issue: 4
Page: 317-323
Authors: Davide Tassinari, Emiliano Tamburini, Lorenzo Gianni, Fabrizio Drudi, Manuela Fantini, Carlotta Santelmo, Lucia Stocchi, Francesco Montanari and Sergio Sartori

New Dehydroepiandrosterone-triazole Derivatives Identified as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Enzyme in the Prostate

Journal: Current Enzyme Inhibition
Volume: 12,Issue: 2
Page: 145-154
Authors: Araceli Sánchez-Márquez, Aylin Silva-Ortíz, Eugene Bratoeff, Yvonne Heuze, Juan Soriano, Yesica Medina and Marisa Cabeza

Zinc Tetrafluoroborate Catalyzed Synthesis, Molecular Docking and Cytotoxicity of Pyrrolidinyl Aminophosphonates

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 2
Page: 139-150
Authors: Sarva Santhisudha, Kandula Madhu Kumar Reddy, Yellapu Nanda Kumar, Ethiraj Selvarajan, Vaithiyalingam Mohanasrinivasan, Sandip Kumar Nayak and Cirandur Suresh Reddy

The Potential of Flavonolignans in Prostate Cancer Management

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 34
Page: 3925-3950
Authors: Bao Vue and Qiao-Hong Chen

Characterization of a New Allelic Variant of Triosephosphate Isomerase from the LNCaP Human Prostate Cancer Cell Line: Enzyme Inhibition and Spectroscopic Studies

Journal: Current Enzyme Inhibition
Volume: 13,Issue: 3
Page: 184-190
Authors: Valeria Guzmán-Luna, Leticia Olvera-Rodríguez, Peniel Bustamante-Villalobos and Gloria Saab-Rincón*

Peptide Therapeutics and the Pharmaceutical Industry: Barriers Encountered Translating from the Laboratory to Patients

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 37
Page: 4231-4259
Authors: John Rafferty, Hema Nagaraj, Alice P. McCloskey, Rawan Huwaitat, Simon Porter, Alyaa Albadr and Garry Laverty

Challenges and Persistent Questions in the Treatment of Trichomoniasis

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 11
Page: 1249-1265
Authors: Patricia de Brum Vieira, Tiana Tasca and W. Evan Secor

Assessment of Poly (vinyl alcohol) Coated Flutamide Nanoparticulates and their Efficacy on Prostate Cancer Cells

Journal: Current Drug Delivery
Volume: 14,Issue: 5
Page: 641-649
Authors: Surenya Renuka Suseelan, Snima Kaniyampadi Sreenivasan, Shantikumar Vasudevan Nair and Vinoth-Kumar Lakshmanan*

Recent Patents on Interventional Robot for Prostate Cancer

Journal: Recent Patents on Mechanical Engineering
Volume: 9,Issue: 4
Page: 281-288
Authors: Yongde Zhang, Weixi Zhang, Yi Liang and Jintao Bi

Highly Disordered Proteins in Prostate Cancer

Journal: Current Protein & Peptide Science
Volume: 18,Issue: 5
Page: 453-481
Authors: Vladimir N. Uversky, Insung Na, Kevin S. Landau and Ryan O. Schenck

Somatic Mutation Analyses in Studies of the Clonal Evolution and Diagnostic Targets of Prostate Cancer

Journal: Current Genomics
Volume: 18,Issue: 3
Page: 236-243
Authors: Dmitry S. Mikhaylenko*, Gennady D. Efremov, Vladimir V. Strelnikov, Dmitry V. Zaletaev and Boris Y. Alekseev

Different Gene Therapy Strategies: A Overview for Prostate Cancer

Journal: Current Gene Therapy
Volume: 16,Issue: 4
Page: 287-291
Authors: Aline Gomes de Souza, Victor Alexandre Felix Bastos, Isaura Beatriz Borges Silva, Karina Marangoni and Vivian Alonso Goulart

Synthesis, Antiproliferative, and Antiangiogenic Activities of Benzochromene and Benzoquinoline Derivatives on Prostate Cancer in vitro

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 4
Page: 398-413
Authors: Gricelda Mata, Juan Rodrigues, Neira Gamboa, Katiuska Charris, Gricela Lobo, Melina Monasterios, Milagros Avendano, Michael Lein, Klaus Jung, Claudia Abramjuk, Bianca Nitzsche, Michael Hopfner and Jaime Charris

Targeted Delivery of Cabazitaxel by Conjugation to Albumin-PEG-folate Nanoparticles Using a Cysteine-acrylate Linker and Simple Synthesis Conditions

Journal: Current Drug Delivery
Volume: 14,Issue: 8
Page: 1120-1129
Authors: Mohammad Kazem Khoeeniha, Mehdi Esfandyari-Manesh, Hossein Behrouz, Mohsen Amini, Behrang Shiri Varnamkhasti, Fatemeh Atyabi and Rassoul Dinarvand*

Hypoxia and Inflammation in Prostate Cancer Progression. Cross-talk with Androgen and Estrogen Receptors and Cancer Stem Cells

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 16,Issue: 4
Page: 235-248
Authors: Matteo Antonio Russo, Linda Ravenna, Laura Pellegrini, Elisa Petrangeli, Luisa Salvatori, Thea Magrone, Massimo Fini and Marco Tafani

Recent Advances in Registration Methods for MRI-TRUS Fusion Image-Guided Interventions of Prostate

Journal: Recent Patents on Engineering
Volume: 11,Issue: 2
Page: 115-124
Authors: Yongde Zhang*, Jintao Bi, Weixi Zhang, Haiyan Du and Yong Xu

Synthesis and Antiproliferative Activity of New pyrazolo[3,4-c]pyridines

Journal: Medicinal Chemistry
Volume: 13,Issue: 4
Page: 365-374
Authors: Efthymios-Spyridon Gavriil, Nikolaos Lougiakis, Nicole Pouli*, Panagiotis Marakos, Alexios-Leandros Skaltsounis, Sangkil Nam, Richard Jove, David Horne, Katerina Gioti, Harris Pratsinis, Dimitris Kletsas and Roxane Tenta

MSD-MAP: A Network-Based Systems Biology Platform for Predicting Disease-Metabolite Links

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 20,Issue: 3
Page: 193-207
Authors: Henri Wathieu, Naiem T. Issa, Manisha Mohandoss, Stephen W. Byers and Sivanesan Dakshanamurthy*

Virus, Oncolytic Virus and Human Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 6
Page: 522-533
Authors: Guang Bin Liu, Liang Zhao, Lifang Zhang and Kong-Nan Zhao*

Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer

Journal: Current Radiopharmaceuticals
Volume: 10,Issue: 1
Page: 6-15
Authors: Giampiero Giovacchini, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello

β3-Adrenoceptor Control of Lower Genitourinary Tract Organs and Function in Male: An Overview

Journal: Current Drug Targets
Volume: 19,Issue: 6
Page: 602-612
Authors: Ecem Kaya, Suresh C Sikka, Didem Yilmaz Oral, Isil Ozakca and Serap Gur*

CYP4Z1 – A Human Cytochrome P450 Enzyme that Might Hold the Key to Curing Breast Cancer

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 14
Page: 2060-2064
Authors: Xu Yang, Michael Hutter, Wilson Wen Bin Goh and Matthias Bureik*

Adiponectin as a Potential Therapeutic Target for Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 28
Page: 4170-4179
Authors: Hanuma Kumar Karnati*, Manas Kumar Panigrahi, Yazhou Li, David Tweedie and Nigel H. Greig*

Optimal Management of Prostate Cancer Based on its Natural Clinical History

Journal: Current Cancer Drug Targets
Volume: 18,Issue: 5
Page: 457-467
Authors: Gaetano Facchini*, Francesco Perri, Gabriella Misso, Carmine D`Aniello, Giuseppina Della Vittoria Scarpati, Sabrina Rossetti, Chiara Della Pepa, Salvatore Pisconti, Gerhard Unteregger, Alessia Cossu, Michele Caraglia, Massimiliano Berretta and Carla Cavaliere

Synthesis and Characterization of Water-soluble Conjugates of Cabazitaxel Hemiesters-Dextran

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 11
Page: 1555-1562
Authors: Elahehnaz Parhizkar, Fatemeh Ahmadi*, Saeid Daneshamouz, Soliman Mohammadi-Samani, Amirhossein Sakhteman and Golnaz Parhizkar

A Rapid, Direct and Validated HPLC- Fluorescence Method for the Quantification of Abiraterone and Abiraterone Acetate in Urine and Serum Samples from Patients with Castration- Resistant Prostate Cancer

Journal: Current Pharmaceutical Analysis
Volume: 14,Issue: 3
Page: 233-238
Authors: Juana Rodriguez*, Gregorio Castaneda, Isabel Lizcano and Jose C. Villa

The Potential Roles of Radionanomedicine and Radioexosomics in Prostate Cancer Research and Treatment

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 20
Page: 2976-2990
Authors: Martin K. Bakht, So W. Oh, Do W. Hwang, Yun-Sang Lee, Hyewon Youn, Lisa A. Porter, Gi J. Cheon*, Cheol Kwak, Dong S. Lee and Keon W. Kang

Decreased HoxD10 Expression Promotes a Proliferative and Aggressive Phenotype in Prostate Cancer

Journal: Current Molecular Medicine
Volume: 17,Issue: 1
Page: 70-78
Authors: R.-J. Mo, J-M Lu, Y.-P. Wan, W. Hua, Y.-X. Liang, Y.-J. Zhuo, Q.-W. Kuang, Y.-L. Liu, H.-C. He and W.-D. Zhong*

Evaluation of Direct Effect of Testosterone on NGEP and LM O1 Expression in LNCaP Prostate Cancer Cells

Journal: Current Biomarkers
Volume: 6,Issue: 2
Page: 97-101
Authors: Monireh Mohsenzadegan, Roya Sharifi, Nafise Taromi and Mohammad M. Farajollahi*

Recent Advances of Hepsin-Targeted Inhibitors

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 21
Page: 2294-2311
Authors: Hongmok Kwon, JooYeon Han, Ki-Yong Lee, Sang-Hyun Son* and Youngjoo Byun*

Cognitive Impacts of Estrogen Treatment in Androgen-Deprived Males: What Needs to be Resolved

Journal: Current Neuropharmacology
Volume: 15,Issue: 7
Page: 1043-1055
Authors: Erik Wibowo*

Integration of DNA Methylation Data and Gene Expression Data for Prostate Adenocarcinoma: A Proof of Concept

Journal: Current Bioinformatics
Volume: 12,Issue: 5
Page: 423-430
Authors: Arpit Singh, Razia Rahman and Yasha Hasija*

Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 7
Page: 603-616
Authors: Nishi Karunasinghe*, Jonathan Masters, Jack U. Flanagan and Lynnette R. Ferguson

Design, Synthesis and Biological Evaluation of Novel 1, 3- thiazolidine-2, 4-diones as Anti-prostate Cancer Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 13
Page: 1756-1768
Authors: Ramakrishnan Elancheran*, Kuppusamy Saravanan, Selvaraj Divakar, Sima Kumari, V. Lenin Maruthanila, Senthamarikannan Kabilan, Muthiah Ramanathan, Rajlakshmi Devi and Jibon Kotoky*

Potential Molecular Targets of Ampelopsin in Prevention and Treatment of Cancers

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 12
Page: 1610-1616
Authors: Xianjuan Kou, Jingjing Fan and Ning Chen*

Drug Resistance of Enzalutamide in CRPC

Journal: Current Drug Targets
Volume: 19,Issue: 6
Page: 613-620
Authors: Xuedong Chen, Jieyang Lu, Liqun Xia and Gonghui Li *

Morphological Characteristics, Geographical Distribution, Secondary Metabolites, and Biological Activities of Taxus

Journal: Mini-Reviews in Organic Chemistry
Volume: 14,Issue: 3
Page: 217-226
Authors: Li Yang*, Xiao Ruan, Xing-Xing Gao, Huan Zhang and Qiang Wang*

Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges

Journal: Current Cancer Drug Targets
Volume: 18,Issue: 3
Page: 222-230
Authors: J. Barroca-Ferreira, J.P. Pais, M.M. Santos, A.M. Goncalves, I.M. Gomes, I. Sousa, S.M. Rocha, L.A. Passarinha and C.J. Maia*

A Survey of Prostate Segmentation Techniques in Different Imaging Modalities

Journal: Current Medical Imaging Reviews
Volume: 14,Issue: 1
Page: 19-46
Authors: Gaurav Garg* and Mamta Juneja

17β-N-arylcarbamoylandrost-4-en-3-one Derivatives as Inhibitors of the Enzymes 3α-Hydroxysteroid Dehydrogenase and 5α-Reductase

Journal: Current Enzyme Inhibition
Volume: 14,Issue: 1
Page: 36-50
Authors: Eugene Bratoeff, Isabel Moreno, Francisco Cortes-Benitez, Yvonne Heuze, Marisol Bravo and Marisa Cabeza*

Synthesis and Antiproliferative Activity of 3-aza Steroids as 5α-reductase Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 11
Page: 1335-1346
Authors: Milanpreet Kaur, Richa Dhingra, T. R. Bhardwaj and Neelima Dhingra*

Urinary Biomarkers for Prostate Cancer

Journal: Current Drug Metabolism
Volume: 18,Issue: 8
Page: 723-726
Authors: Francesca Giunchi, Chiara Ciccarese, Rodolfo Montironi, Marina Scarpelli, Antonio Lopez-Beltran, Liang Cheng, Holger Moch, Francesco Massari and Michelangelo Fiorentino*

Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?

Journal: Current Drug Metabolism
Volume: 18,Issue: 8
Page: 692-699
Authors: Chiara Ciccarese, Rodolfo Montironi, Michelangelo Fiorentino, Guido Martignoni, Matteo Brunelli, Roberto Iacovelli, Antonio Lopez-Beltran, Liang Cheng, Marina Scarpelli, Holger Moch, Giampaolo Tortora and Francesco Massari*

Metal-free Reductive Coupling of Biphenyl Tosylhydrazones with Phenols or Benzyl Alcohols

Journal: Letters in Organic Chemistry
Volume: 14,Issue: 10
Page: 748-757
Authors: Yang Liu, Ping Liu*, Yan Liu, Yu Wei* and Bin Dai

Past and Present of Imaging Modalities Used for Prostate Cancer Diagnosis: Androgen Receptor Targeted Imaging of Prostate Cancer as a Future Modality for Early, Rapid and Efficient Diagnosis

Journal: Current Medical Imaging Reviews
Volume: 13,Issue:
Page: 1-13
Authors: Touba Khaliq, Rashid Rasheed, Syed Muhammad Fareed Hassan, Saira Azhar , Naveed Ullah, Syed Jawad Ali Gillani, Nazish Jabeen and Ghulam Murtaza*

Molecular Tests for the Choice of Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 32
Page: 4794-4806
Authors: Anna P. Sokolenko and Evgeny N. Imyanitov*

Advanced Methods for the Analysis of Testosterone

Journal: Current Medicinal Chemistry
Volume: 24,Issue:
Page: 1-13
Authors: Livia Alexandra Gugoasa* and Raluca Ioana Stefan-van Staden

Anethole Inhibits the Proliferation of Human Prostate Cancer Cells via Induction of Cell Cycle Arrest and Apoptosis

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18,Issue: 2
Page: 216-236
Authors: Ayman I. Elkady*

Personalized & Precision Medicine in Cancer: A Theranostic Approach

Journal: Current Radiopharmaceuticals
Volume: 10,Issue: 3
Page: 166-170
Authors: Partha Choudhury* and Manoj Gupta

ARRDC3 Inhibits the Progression of Human Prostate Cancer Through ARRDC3-ITGβ4 Pathway

Journal: Current Molecular Medicine
Volume: 17,Issue: 3
Page: 221-229
Authors: Y. Zheng, Z.-Y. Lin, J.-J. Xie, F.-N. Jiang, C.-J. Chen, J.-X. Li, X. Zhou and W.-D. Zhong*

Bone Imaging in Metastatic Castration-resistant Prostate Cancer; Where do we Stand

Journal: Current Radiopharmaceuticals
Volume: 10,Issue: 3
Page: 171-177
Authors: Petros Sountoulides* and Linda Metaxa

Ultrasensitive Electrochemical Sensors for PSA Detection: Related Surface Functionalization Strategies

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 26
Page: 2913-2925
Authors: Nesrine Blel, Najla Fourati*, Mina Souiri, Chouki Zerrouki, Asma Omezzine, Ali Bouslama and Ali Othmane

Disorders of Mechanisms of Calcium Metabolism Control as Potential Risk Factors of Prostate Cancer

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 38
Page: 4229-4244
Authors: Dorota Skrajnowska , Barbara Bobrowska-Korczak* and Andrzej Tokarz

Determination of Related Substances in Estradiol Valerate Tablet by Use of HPLC Method

Journal: Current Pharmaceutical Analysis
Volume: 14,Issue: 5
Page: 513-518
Authors: Biying Du*

A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 17,Issue: 4
Page: 276-284
Authors: Nur-Vaizura Mohamad, Ima-Nirwana Soelaiman and Kok-Yong Chin*

11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients

Journal: Current Radiopharmaceuticals
Volume: 10,Issue: 3
Page: 195-202
Authors: Elena Incerti, Vincenzo Gangemi, Paola Mapelli, Chiara Lucrezia Deantoni, Giampiero Giovacchini, Federico Fallanca, Andrei Fodor, Andrea Ciarmiello, Sergio Baldari, Luigi Gianolli, Nadia Di Muzio and Maria Picchio*

Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity

Journal: Medicinal Chemistry
Volume: 14,Issue: 4
Page: 333-343
Authors: Maya Z. Gibson, Minh A. Nguyen and Sarah K. Zingales*

An Overview on Applications of Gold Nanoparticle for Early Diagnosis and Targeted Drug Delivery to Prostate Cancer

Journal: Recent Patents on Nanotechnology
Volume: 12,Issue: 2
Page: 110-131
Authors: Selvarathinam Thambiraj, Soundararajan Hema and Dhesingh Ravi Shankaran*

PET/CT With 68Ga-PSMA in Prostate Cancer: Radiopharmaceutical Background and Clinical Implications

Journal: Current Radiopharmaceuticals
Volume: 11,Issue: 1
Page: 4-13
Authors: Giampiero Giovacchini*, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello

Degradation of Androgen Receptor through Small Molecules for Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 17,Issue:
Page: 1-16
Authors: Raoling Ge, Xi Xu, Pengfei Xu, Lei Li, Zhiyu Li* and Jinlei Bian

AR Copy Number and AR Signaling-directed Therapies in Castrationresistant Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 17,Issue:
Page: 1-8
Authors: Samanta Salvi*, Vincenza Conteduca, Cristian Lolli, Sara Testoni, Valentina Casadio, Andrea Zaccheroni, Lorena Rossi, Salvatore Luca Burgio, Cecilia Menna, Giuseppe Schepisi and Ugo De Giorgi

Design, Synthesis and Cytotoxicity Evaluation of New 3, 5-Disubstituted-2- Thioxoimidazolidinones

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18,Issue: 4
Page: 573-582
Authors: Khaled R.A. Abdellatif*, Mostafa M. Elbadawi, Mohammed T. Elsaady, Amer A. Abd El-Hafeez, Takashi Fujimura, Seiji Kawamoto and Ahmed I. Khodair

Inhibition of Intercellular Communication between Prostate Cancer Cells by a Specific Anti-STEAP-1 Single Chain Antibody

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18,Issue:
Page: 1-6
Authors: Seyed-Alireza Esmaeili, Foroogh Nejatollahi* and Amirhossein Sahebkar

Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer

Journal: Current Molecular Medicine
Volume: 17,Issue: 6
Page: 405-420
Authors:

SOCS6 Functions as a Tumor Suppressor by Inducing Apoptosis and Inhibiting Angiogenesis in Human Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 18,Issue:
Page: 1-11
Authors: Dongbo Yuan*, Wei Wang*, Jiaming Su*, Yongqiang Zhang, Boshi Luan, Haofu Rao, Tianfei Cheng, Wei Zhang, Shiwei Xiao, Mingsheng Zhang, Fu-Neng Jiang, Zhaolin Sun, Zhenyu Jia, Wei-De Zhong and Jianguo Zhu

Latest Evidence on the Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Insignificant Prostate Cancer: A Systematic Review

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18,Issue:
Page: 1-5
Authors: Francesco Cantiello*, Stefano Manno, Antonio Cicione and Rocco Damiano

Stereotactic Body Radiotherapy (SBRT) in the Management of Clinically Localized Prostate Cancer: Where are We Now?

Journal: Current Cancer Therapy Reviews
Volume: 14,Issue: 1
Page: 31-45
Authors: Mack Roach*, Nora Fahim, Michael Wahl , Soha A. Ahmed and Martina Descovich

Anti-Oxidants as Chemopreventive Agents in Prostate Cancer: A Gap Between Preclinical and Clinical Studies

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13,Issue: 2
Page: 224-239
Authors: Monireh Mohsenzadegan*, Farhad Seif, Mohammad M. Farajollahi and Majid Khoshmirsafa

Delivery of Peptidic Gonadotropin Releasing Hormone Antagonists

Journal: Current Drug Delivery
Volume: 15,Issue: 5
Page: 602-609
Authors: Rawda Y. AlSheyyab*, Bashar M. Al-Taani, Rana M. Obeidat, Motasem M. Alsmadi, Rafeef K. Masaedeh and Raghda N. Sabat

Riluzole Inhibits Proliferation, Migration and Cell Cycle Progression and Induces Apoptosis in Tumor Cells of Various Origins

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18,Issue: 4
Page: 565-572
Authors: Marta Kinga Lemieszek*, Andrzej Stepulak, Katarzyna Sawa-Wejksza, Arkadiusz Czerwonka, Chrysanthy Ikonomidou and Wojciech Rzeski

Apoptosis Caused by Triterpenes and Phytosterols and Antioxidant Activity of an Enriched Flavonoid Extract from Passiflora mucronata

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18,Issue:
Page: 1-12
Authors: Isabel Cristina Vieira da Silva, Goran Kaluderovic, Pollyana Felix de Oliveira, Denise Oliveira Guimaraes, Carla Holandino Quaresma, Andrea Porzel, Michelle Frazao Muzitano, Ludger A. Wessjohann and Ivana Correa Ramos Leal*

Role of MicroRNAs in Treatment Response in Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 18,Issue:
Page: 1-16
Authors: Anshuli Razdan, Paul de Souza* and Tara Laurie Roberts

Treatment of Metastatic, Castration-Resistant, Docetaxel-Resistant Prostate Cancer: A Systematic Review of Literature With a Network Meta- Analysis of Randomized Clinical Trials

Journal: Reviews on Recent Clinical Trials
Volume: 13,Issue: 3
Page: 226-237
Authors: Davide Tassinari*, Chiara Cherubini, Britt Roudnas, Emiliano Tamburini, Fabrizio Drudi, Emanuela Bianchi, Manuela Fantini, Francesco Montanari and Sergio Sartori

Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial

Journal: Reviews on Recent Clinical Trials
Volume: 13,Issue:
Page: 1-17
Authors: Philip C. Prorok*, Patrick Wright, Thomas R. Riley, Barnett S. Kramer, Christine D. Berg and John K. Gohagan

An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

Journal: Current Radiopharmaceuticals
Volume: 11,Issue:
Page: 1-9
Authors: Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer

Synthesis and Evaluation of Arylpiperazine Derivatives as Anti-cancer Agents

Journal: Letters in Organic Chemistry
Volume: 15,Issue:
Page: 1-9
Authors: Hong Chen, Zonglin Yang, Tao Sun, Jiangxiu Niu, Xiumei Tian* and Mu Yuan

Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer–A Single Institution Experience

Journal: Current Radiopharmaceuticals
Volume: 11,Issue: 2
Page: 152-157
Authors: Kalevi Kairemo , Denai R. Milton, Elba Etchebehere, Eric M. Rohren and Homer A. Macapinlac*